VNUE (VNUE) S-1 14 Feb 22 IPO registration Financial data

Cover

Cover	9 Months Ended
	Sep. 30, 2021
Cover [Abstract]
Document Type	S-1
Amendment Flag	false
Entity Registrant Name	VNUE, INC.
Entity Central Index Key	0001376804
Entity Tax Identification Number	98-0543851
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	104 West 29th Street,
Entity Address, Address Line Two	11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10001
City Area Code	833
Local Phone Number	937-5493
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 4,458	$ 52,096
Prepaid expenses	100,000
Total current assets	104,458	52,096
Total assets	104,458	52,096
Current liabilities:
Accounts payable and accrued expenses	2,372,072	1,018,145
Shares to be issued	247,707
Accrued payroll-officers	209,750	68,000
Advances from former officer	720	720
Notes payable	34,000	34,000
Deferred revenue	74,225
Convertible notes payable, net	1,956,922	1,486,067
Purchase liability	300,000	300,000
Derivative liability	3,156,582	922,509
Total current liabilities	8,351,979	3,829,441
Total liabilities	8,351,979	3,829,441
Stockholders’ Deficit
Preferred stock, par value $0.0001: 20,000,000 shares authorized 4,126,776 issued and outstanding	413	413
Common stock, par value $0.0001, 2,000,000,000 shares authorized; 1,211,495,162 and 770,883,602 shares issued and outstanding, respectively	121,149	77,088
Additional paid-in capital	8,386,593	8,099,346
Common stock to be issued, 5,204,352 and 5,204,352 shares, respectively		247,707
Accumulated deficit	(16,755,676)	(12,201,899)
Total stockholders’ deficit	(8,247,521)	(3,777,345)
Total Liabilities and Stockholders’ Deficit	$ 104,458	$ 52,096

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	20,000,000	20,000,000	20,000,000
Preferred stock, shares issued	4,250,579	4,126,776	4,126,776
Preferred stock, shares outstanding	4,250,579	4,126,776	4,126,776
Common stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares issued	1,372,757,161	1,211,495,162	770,883,602
Common stock, shares outstanding	1,372,757,161	1,211,495,162	770,883,602
Common stock to be issued, shares	5,204,352	5,204,352	5,204,352	5,204,352

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenues - related party	$ 22,474	$ 206,161
Direct costs of revenue	8,509	211,031
Gross margin (loss)	13,965	(4,870)
Operating expenses:
Research and development		12,404
General and administrative	601,022	1,177,756
Intangible asset impairment		132,397
Total costs and expenses	601,022	1,322,557
Operating loss	(587,058)	(1,327,427)
Other income (expense), net
Change in fair value of derivative liability	(2,234,073)	1,179,556
Loss on the extinguishment of debt	(263,609)	(532,529)
Gain on settlement of obligations		35,534
Financing costs	(1,469,037)	(755,232)
Other income (expense), net	(3,966,719)	(72,671)
Net income (loss)	$ (4,553,777)	$ (1,400,098)
Net loss per common share - basic and diluted	$ 0	$ 0
Weighted average common shares outstanding:
Basic and diluted	1,135,193,463	447,194,161

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Shares To Be Issued [Member]	Retained Earnings [Member]	Total
Balance - December 31, 2019 at Dec. 31, 2018		$ 10,563	$ 6,493,070	$ 243,839	$ (10,801,801)	$ (4,054,329)
Balance, shares at Dec. 31, 2018		105,635,816
Shares issued upon conversion of notes payable		$ 64,028	895,262			959,290
Shares issued upon conversion of notes payable, shares		640,276,078
Issuance of Series A Preferred Stock	$ 413		589,716			590,129
Issuance of Series A Preferred Stock, shares	4,127,776
Shares issued for settlement of accounts payable to former officer		$ 1,143	29,714			30,857
Shares issued for settlement of accounts payable to former officer, shares		11,428,571
Shares issued for settlement of accounts payable		$ 54	650			704
Shares issued for settlement of accounts payable, shares		541,912
Shares issued on conversion of accrued payroll to officers		$ 1,506	39,149			40,654
Shares issued on conversion of accrued payroll to officers, shares		15,057,143
Gain on extinguishment of accrued payroll to officers recorded as contributed capital			12,046			12,046
Shares to be issued for financing cost				3,500		3,500
Shares to be issued for services		$ 250	2,750	368		3,368
Shares to be issued for services, shares		2,500,000
Shares returned by former officer		$ (456)	456
Shares returned by former officer, shares		(4,555,918)				4,555,918
Warrants issued for notes amendment			36,533			$ 36,533
Net income (loss)					(1,400,098)	(1,400,098)
December 31, 2020 at Dec. 31, 2019	$ 413	$ 77,088	8,099,346	247,707	(12,201,899)	(3,777,345)
Balance, shares at Dec. 31, 2019	4,127,776	770,883,602
Net income (loss)					(639,557)	(639,557)
December 31, 2020 at Mar. 31, 2020	$ 413	$ 114,975	8,182,767		(12,841,456)	(4,543,301)
Balance, shares at Mar. 31, 2020	4,127,776	1,149,756,152
Balance - December 31, 2019 at Dec. 31, 2019	$ 413	$ 77,088	8,099,346	247,707	(12,201,899)	(3,777,345)
Balance, shares at Dec. 31, 2019	4,127,776	770,883,602
Net income (loss)						(7,372,653)
December 31, 2020 at Sep. 30, 2020	$ 413	$ 120,775	8,378,367		(19,574,552)	(11,074,997)
Balance, shares at Sep. 30, 2020	4,127,776	1,207,756,152
Balance - December 31, 2019 at Dec. 31, 2019	$ 413	$ 77,088	8,099,346	247,707	(12,201,899)	(3,777,345)
Balance, shares at Dec. 31, 2019	4,127,776	770,883,602
Net income (loss)					(4,553,777)	(4,553,777)
To reclassify shares to be issued to a liability				(247,707)		(247,707)
Conversion of notes payable to common shares		$ 42,257	277,817			320,074
Conversion of notes payable to common shares, shares		422,572,017
Shares issued to pay interest expense		$ 1,754	9,330			11,084
Shares issued to pay interest expense, shares		17,539,543
Shares issued for services		$ 50	100			150
Shares issued for services, shares		500,000
December 31, 2020 at Dec. 31, 2020	$ 413	$ 121,149	8,386,593		(16,755,676)	(8,247,521)
Balance, shares at Dec. 31, 2020	4,127,776	1,211,495,162
Balance - December 31, 2019 at Jun. 30, 2020	$ 413	$ 114,975	8,182,767		(12,700,321)	(4,402,166)
Balance, shares at Jun. 30, 2020	4,127,776	1,149,756,152
Net income (loss)					(6,874,231)	(6,874,231)
December 31, 2020 at Sep. 30, 2020	$ 413	$ 120,775	8,378,367		(19,574,552)	(11,074,997)
Balance, shares at Sep. 30, 2020	4,127,776	1,207,756,152
Balance - December 31, 2019 at Dec. 31, 2020	$ 413	$ 121,149	8,386,593		(16,755,676)	(8,247,521)
Balance, shares at Dec. 31, 2020	4,127,776	1,211,495,162
Net income (loss)						3,350,043
December 31, 2020 at Sep. 30, 2021	$ 425	$ 137,275	10,548,671		(13,405,633)	(2,719,262)
Balance, shares at Sep. 30, 2021	4,250,579	1,372,757,161
Balance - December 31, 2019 at Mar. 31, 2021	$ 413	$ 121,149	8,498,358		(14,764,575)	(6,144,656)
Balance, shares at Mar. 31, 2021	4,127,776	1,211,495,162
Net income (loss)					1,724,104	1,724,104
December 31, 2020 at Jun. 30, 2021	$ 425	$ 128,669	9,772,348		(13,040,472)	(3,139,030)
Balance, shares at Jun. 30, 2021	4,250,579	1,286,690,336
Net income (loss)					(365,161)	(365,161)
December 31, 2020 at Sep. 30, 2021	$ 425	$ 137,275	$ 10,548,671		$ (13,405,633)	$ (2,719,262)
Balance, shares at Sep. 30, 2021	4,250,579	1,372,757,161

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash Flows From Operating Activities:
Net income (loss)	$ (4,553,777)	$ (1,400,098)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Change in the fair value of derivatives	2,234,073	(1,179,556)
Derivative value considered financing costs		138,828
Gain on the settlement of vendor obligations		(35,534)
Loss on the extinguishment of debt		532,529
Amortization of debt discount	78,013	389,793
Amortization of intangible assets		101,032
Impairment of intangible assets		132,397
Warrants issued for financing costs		36,533
Issuance of preferred stock for services		590,129
Shares issued for financing costs	253,194	3,500
Shares issued for services	100	3,368
Changes in operating assets and liabilities
Gain on debt forgiveness		(15,500)
Prepaid expenses	(100,000)	666
Accounts payable and accrued interest	1,395,177	132,008
Deferred revenue	74,225
Accrued payroll officers	100,500	68,000
Net cash (used in) operating activities	(518,493)	(501,905)
Cash Flows From Investing Activities:
Proceeds from notes payable		25,000
Payoff of convertible note	(45,134)	(30,000)
Proceeds from the issuance of convertible notes	515,989	540,810
Net cash provided by investing activities	470,855	535,810
Net Increase (Decrease) In Cash	(47,638)	33,905
Cash At The Beginning Of The Period	52,096	18,191
Cash At The End Of The Period	4,458	52,096
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Non-Cash Financing Activities
Common shares issued upon conversion of notes payable and accrued interest		959,290
Common shares issued in settlement of accounts payable and accrued expenses		31,561
Common shares issued upon conversion of accrued payroll		40,654
Fair value of derivative created upon issuance of convertible debt recorded as debt discount		218,637
Capital contribution upon conversion of accrued payroll for officer/shareholder		$ 12,046

CONDENSED CONSOLIDATED BALANC_3

CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 207,921	$ 4,458
Prepaid expenses	295,000	100,000
Total current assets	502,921	104,458
Total assets	502,921	104,458
Current liabilities:
Accounts payable and accrued expenses	834,910	2,372,072
Shares to be issued	247,707	247,707
Accrued payroll-officers	239,750	209,750
Advances from former officer	720	720
Advances from officer	10,000
Notes payable	879,157	34,000
Deferred revenue	74,225	74,225
Convertible notes payable, net	635,714	1,956,922
Purchase liability	300,000	300,000
Derivative liability		3,156,582
Total current liabilities	3,222,183	8,351,979
Total liabilities	3,222,183	8,351,979
Stockholders' Deficit
Preferred stock, par value $0.0001: 20,000,000 shares authorized;4,250,579 issued and outstanding as of September 30, 2021, and December 31, 2020	425	413
Common stock, par value $0.0001, 2,000,000,000 shares authorized; 1,372,757,161 and 1,211,495,162 shares issued and outstanding, as of September 30, 2021, and December 31, 2020, respectively	137,275	121,149
Additional paid-in capital	10,548,671	8,386,593
Accumulated deficit	(13,405,633)	(16,755,676)
Total stockholders’ deficit	(2,719,262)	(8,247,521)
Total Liabilities and Stockholders’ Deficit	$ 502,921	$ 104,458

CONDENSED CONSOLIDATED BALANC_4

CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	20,000,000	20,000,000	20,000,000
Preferred stock, shares issued	4,250,579	4,126,776	4,126,776
Preferred stock, shares outstanding	4,250,579	4,126,776	4,126,776
Common stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares issued	1,372,757,161	1,211,495,162	770,883,602
Common stock, shares outstanding	1,372,757,161	1,211,495,162	770,883,602

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenues - related party	$ 2,714	$ 1,746	$ 9,295	$ 19,932
Direct costs of revenue	5,380		5,446	8,509
Gross margin (loss)	(2,666)	1,746	3,849	11,423
Operating expenses:
General and administrative	279,884	106,990	614,796	477,021
Total costs and expenses	279,884	106,990	614,796	477,021
Operating loss	(282,550)	(105,244)	(610,947)	(465,598)
Other income (expense), net
Change in fair value of derivative liability		(6,519,216)	3,156,582	(6,413,154)
Other income			1,172,781
Loss on the extinguishment of debt		(190,900)	(80,227)	(263,609)
Financing costs	(82,611)	(58,872)	(288,146)	(230,292)
Other income (expense), net	(82,611)	(6,768,988)	3,960,990	(6,907,055)
Net income (loss)	$ (365,161)	$ (6,874,231)	$ 3,350,043	$ (7,372,653)
Net loss per common share - basic and diluted	$ 0	$ (0.01)	$ 0	$ (0.01)
Weighted average common shares outstanding:
Basic and diluted	1,341,926,621	1,150,881,152	1,266,155,076	1,070,105,622

(UNAUDITED) CONDENSED CONSOLIDA

(UNAUDITED) CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - December 31, 2019 at Dec. 31, 2018		$ 10,563	$ 6,493,070	$ (10,801,801)	$ (4,054,329)
Balance, shares at Dec. 31, 2018		105,635,816
Net loss				(1,400,098)	(1,400,098)
December 31, 2020 at Dec. 31, 2019	$ 413	$ 77,088	8,099,346	(12,201,899)	(3,777,345)
Balance, shares at Dec. 31, 2019	4,127,776	770,883,602
Shares issued on conversion of notes payable		$ 37,887	83,421		121,308
Shares issued upon conversion of convertible notes payable, shares		378,872,550
Net loss				(639,557)	(639,557)
December 31, 2020 at Mar. 31, 2020	$ 413	$ 114,975	8,182,767	(12,841,456)	(4,543,301)
Balance, shares at Mar. 31, 2020	4,127,776	1,149,756,152
Balance - December 31, 2019 at Dec. 31, 2019	$ 413	$ 77,088	8,099,346	(12,201,899)	(3,777,345)
Balance, shares at Dec. 31, 2019	4,127,776	770,883,602
Net loss					(7,372,653)
December 31, 2020 at Sep. 30, 2020	$ 413	$ 120,775	8,378,367	(19,574,552)	(11,074,997)
Balance, shares at Sep. 30, 2020	4,127,776	1,207,756,152
Balance - December 31, 2019 at Dec. 31, 2019	$ 413	$ 77,088	8,099,346	(12,201,899)	(3,777,345)
Balance, shares at Dec. 31, 2019	4,127,776	770,883,602
Net loss				(4,553,777)	(4,553,777)
December 31, 2020 at Dec. 31, 2020	$ 413	$ 121,149	8,386,593	(16,755,676)	(8,247,521)
Balance, shares at Dec. 31, 2020	4,127,776	1,211,495,162
Balance - December 31, 2019 at Mar. 31, 2020	$ 413	$ 114,975	8,182,767	(12,841,456)	(4,543,301)
Balance, shares at Mar. 31, 2020	4,127,776	1,149,756,152
Net income				141,135	141,135
December 31, 2020 at Jun. 30, 2020	$ 413	$ 114,975	8,182,767	(12,700,321)	(4,402,166)
Balance, shares at Jun. 30, 2020	4,127,776	1,149,756,152
Net loss				(6,874,231)	(6,874,231)
Shares issued upon conversion of convertible notes payable		$ 5,750	195,500		201,250
Conversion of convertible notes to common shares, shares		57,500,000
Shares issued for services		$ 50	100		150
Shares issued for services, shares		500,000
December 31, 2020 at Sep. 30, 2020	$ 413	$ 120,775	8,378,367	(19,574,552)	(11,074,997)
Balance, shares at Sep. 30, 2020	4,127,776	1,207,756,152
Balance - December 31, 2019 at Dec. 31, 2020	$ 413	$ 121,149	8,386,593	(16,755,676)	(8,247,521)
Balance, shares at Dec. 31, 2020	4,127,776	1,211,495,162
Net income				1,991,101	1,991,101
Beneficial conversion feature of convertible notes			111,765		111,765
December 31, 2020 at Mar. 31, 2021	$ 413	$ 121,149	8,498,358	(14,764,575)	(6,144,656)
Balance, shares at Mar. 31, 2021	4,127,776	1,211,495,162
Balance - December 31, 2019 at Dec. 31, 2020	$ 413	$ 121,149	8,386,593	(16,755,676)	(8,247,521)
Balance, shares at Dec. 31, 2020	4,127,776	1,211,495,162
Net loss					3,350,043
December 31, 2020 at Sep. 30, 2021	$ 425	$ 137,275	10,548,671	(13,405,633)	(2,719,262)
Balance, shares at Sep. 30, 2021	4,250,579	1,372,757,161
Balance - December 31, 2019 at Mar. 31, 2021	$ 413	$ 121,149	8,498,358	(14,764,575)	(6,144,656)
Balance, shares at Mar. 31, 2021	4,127,776	1,211,495,162
Shares issued upon conversion of convertible notes payable, shares	123,803	75,195,174
Net loss				1,724,104	1,724,104
Shares issued upon conversion of convertible notes payable	$ 12	$ 7,520	1,273,991		1,281,523
December 31, 2020 at Jun. 30, 2021	$ 425	$ 128,669	9,772,348	(13,040,472)	(3,139,030)
Balance, shares at Jun. 30, 2021	4,250,579	1,286,690,336
Net loss				(365,161)	(365,161)
Private placement of common shares		$ 8,607	776,323		784,929
Private placement of common shares, shares		86,066,825
December 31, 2020 at Sep. 30, 2021	$ 425	$ 137,275	$ 10,548,671	$ (13,405,633)	$ (2,719,262)
Balance, shares at Sep. 30, 2021	4,250,579	1,372,757,161

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows From Operating Activities:
Net income (loss)	$ 3,350,043	$ (7,372,653)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Change in the fair value of derivatives	(3,156,582)	6,413,154
Derivative value considered financing costs		244,696
Loss on the extinguishment of debt	80,227
Amortization of debt discount	111,765	78,013
Changes in operating assets and liabilities
Prepaid expenses	(195,000)	(100,000)
Accounts payable and accrued interest	(1,133,919)	161,843
Deferred revenue		74,225
Accrued payroll officers	30,000	78,000
Net cash (used in) operating activities	(913,466)	(422,722)
Cash Flows From Financing Activities:
Advances from officers	10,000
Payments on promissory note	(12,000)
Payment of convertible note		(45,134)
Proceeds from the private placement of common shares	784,929
Proceeds from the issuance of convertible notes	334,000	426,989
Net cash provided by investing activities	1,116,929	381,855
Net Increase (Decrease) In Cash	203,463	(40,867)
Cash At The Beginning Of The Period	4,458	52,096
Cash At The End Of The Period	207,921	11,229
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash information:
Common shares issued upon conversion of notes payable and accrued interest	$ 1,281,523	$ 322,558

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2020		Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 4,458		$ 52,096
Prepaid expense	100,000
Total current assets	104,458		52,096
Total assets	104,458		52,096
Current liabilities:
Accrued liabilities	466,801		271,621
Accrued interest	2,372,072		1,018,145
Notes payable	34,000		34,000
Convertible notes	1,956,922		1,486,067
Total current liabilities	8,351,979		3,829,441
Total liabilities	8,351,979		3,829,441
Preferred Stock value	413		413
Common stock, $0.0001 par value, 20,000,000 shares authorized, 972,614 shares issued and outstanding as of December 31, 2020 and 2019	121,149		77,088
Additional paid in capital	8,386,593		8,099,346
Accumulated deficit	(16,755,676)		(12,201,899)
Total stockholders’ deficit	(8,247,521)		(3,777,345)
Total Liabilities and Stockholders’ Deficit	104,458		52,096
Stage It Corp [Member]
Current assets:
Cash and cash equivalents	281,003		88,457
Prepaid expense			1,288
Other assets	127,874		118,795
Total current assets	408,877		208,540
Fixed assets -net	62,912
Total assets	471,789		208,540
Current liabilities:
Accounts payable	427,087		223,795
Accrued liabilities	1,785,861		699,914
Accrued interest	650,654		502,916
Accrued interest -related party	767,715		617,891
Notes payable	179,000	[1]	179,000
Convertible notes -related party	547,500		547,500
Convertible notes	315,000		315,000
Derivative liability	2,404,981		2,099,025
Total current liabilities	7,077,798		5,185,041
Total liabilities	7,077,798		5,185,041
Commitments and contingencies
Common stock, $0.0001 par value, 20,000,000 shares authorized, 972,614 shares issued and outstanding as of December 31, 2020 and 2019	97		97
Additional paid in capital	3,963,327		3,963,327
Accumulated deficit	(10,569,502)		(8,939,994)
Total stockholders’ deficit	(6,606,009)		(4,976,502)
Total Liabilities and Stockholders’ Deficit	471,789		208,540
Stage It Corp [Member] | Preferred Stock A [Member]
Current liabilities:
Preferred Stock value	4		4
Stage It Corp [Member] | Preferred Stock A 1 [Member]
Current liabilities:
Preferred Stock value	25		25
Stage It Corp [Member] | Preferred Stock A 2 [Member]
Current liabilities:
Preferred Stock value	20		20
Stage It Corp [Member] | Preferred Stock A 3 [Member]
Current liabilities:
Preferred Stock value	$ 20		$ 20
[1]	Notes payable are comprised of a note for $179,000 at 15% interest in both period that is past due, a promissory note for $250,000 at 15% interest, advances of $35,000, and $415,922 in loans under the terms of revenue factoring agreement with three different lenders at an average rate of _____%

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	20,000,000	20,000,000	20,000,000
Preferred stock, shares issued	4,250,579	4,126,776	4,126,776
Preferred stock, shares outstanding	4,250,579	4,126,776	4,126,776
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares issued	1,372,757,161	1,211,495,162	770,883,602
Common stock, shares outstanding	1,372,757,161	1,211,495,162	770,883,602
Stage It Corp [Member]
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000	20,000,000
Common stock, shares issued	972,614	972,614	972,614
Common stock, shares outstanding	972,614	972,614	972,614
Preferred Stock A [Member] | Stage It Corp [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	400,000	400,000	400,000
Preferred stock, shares issued	40,000	40,000	40,000
Preferred stock, shares outstanding	40,000	40,000	40,000
Preferred Stock A 1 [Member] | Stage It Corp [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	3,000,000	3,000,000	3,000,000
Preferred stock, shares issued	246,543	246,543	246,543
Preferred stock, shares outstanding	246,543	246,543	246,543
Preferred Stock A 2 [Member] | Stage It Corp [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	2,000,000	2,000,000	2,000,000
Preferred stock, shares issued	200,000	200,000	200,000
Preferred stock, shares outstanding	200,000	200,000	200,000
Preferred Stock A 3 [Member] | Stage It Corp [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	300,000	300,000	300,000
Preferred stock, shares issued	196,522	196,522	196,522
Preferred stock, shares outstanding	196,522	196,522	196,522

Statements of Operations

Statements of Operations - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
General and administrative expenses	$ 279,884		$ 106,990		$ 614,796	$ 477,021	$ 601,022	$ 1,177,756
Operating loss	(282,550)		(105,244)		(610,947)	(465,598)	(587,058)	(1,327,427)
Other income (expense)
Interest expense							(15,630)	(5,630)
Other income (expense), net							(3,966,719)	(72,671)
Net income (loss)	$ (365,161)	$ 1,724,104	$ (6,874,231)	$ (639,557)	$ 3,350,043	$ (7,372,653)	$ (4,553,777)	$ (1,400,098)
Basic and diluted earnings (loss) per common share	$ 0		$ (0.01)		$ 0	$ (0.01)	$ 0	$ 0
Weighted-average number of common shares outstanding:
Basic and diluted	1,341,926,621		1,150,881,152		1,266,155,076	1,070,105,622	1,135,193,463	447,194,161
Stage It Corp [Member]
Revenue-net					$ 313,811	$ 895,145	$ 890,846	$ (4,809)
Operating expenses:
General and administrative expenses					212,728	122,032	231,340	51,764
Contractor expenses					259,686	242,963	455,028	1,805
Payroll expense					1,320,436	658,317	1,142,057	41,331
Legal and professional fees					114,150	36,365	88,411
Total operating expenses					2,398,265	1,059,677	1,916,836	94,900
Operating loss					(2,084,454)	(164,532)	(1,025,990)	(99,709)
Other income (expense)
Change in derivative liability					(265,182)	(229,467)	(305,956)	(2,099,025)
Interest expense					(464,023)	(223,172)	(297,562)	(257,289)
Other income (expense), net					(729,205)	(452,639)	(603,518)	(2,356,314)
Net income (loss)					$ (2,813,659)	$ (617,171)	$ (1,629,508)	$ (2,456,023)
Basic and diluted earnings (loss) per common share					$ (2.89)	$ (0.63)	$ (1.68)	$ (2.53)
Weighted-average number of common shares outstanding:
Basic and diluted					972,614	972,614	972,614	972,614

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net loss	$ (4,553,777)	$ (1,400,098)
Change in balance sheet accounts
Prepaid expenses	(100,000)	666
Accrued interest	100,500	68,000
Derivative liability	2,234,073	(1,179,556)
Net cash (used in) operating activities	(518,493)	(501,905)
Cash flows from investing activities
Net cash provided by investing activities	470,855	535,810
Net Increase (Decrease) In Cash	(47,638)	33,905
Cash At The Beginning Of The Period	52,096	18,191
Cash At The End Of The Period	4,458	52,096
Stage It Corp [Member]
Cash flows from operating activities
Net loss	(1,629,508)	(2,456,023)
Depreciation	4,468
Change in balance sheet accounts
Prepaid expenses	1,288	(1,288)
Other assets	(9,079)	(21,834)
Accounts payable	203,292	13,795
Accrued liabilities	1,085,947	98,529
Accrued interest	297,562	257,289
Derivative liability	305,956	2,099,025
Net cash (used in) operating activities	259,926	(10,506)
Cash flows from investing activities
Purchase of fixed assets	(67,380)
Net cash provided by investing activities	(67,380)
Net Increase (Decrease) In Cash	192,546	(10,506)
Cash At The Beginning Of The Period	88,457	98,963
Cash At The End Of The Period	281,003	88,457
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity - Stage It Corp [Member] - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series A One [Member]	Preferred Stock Series A Two [Member]	Preferred Stock Series A Three [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total [Member]
Balance - December 31, 2019 at Dec. 31, 2018	$ 4	$ 25	$ 20	$ 20	$ 97	$ 3,963,327	$ (6,483,971)	$ (2,520,478)
Balance, shares at Dec. 31, 2018	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(2,456,023)	(2,456,023)
December 31, 2020 at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Balance - December 31, 2019 at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(617,171)	(617,171)
December 31, 2020 at Sep. 30, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(9,557,166)	(5,593,672)
Balance, shares at Sep. 30, 2020	40,000	246,543	200,000	196,522	972,614
Balance - December 31, 2019 at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(1,629,508)	(1,629,508)
December 31, 2020 at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(10,569,502)	(6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614
December 31, 2020 at Sep. 30, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(9,557,166)	(5,593,672)
Balance, shares at Sep. 30, 2020	40,000	246,543	200,000	196,522	972,614
Balance - December 31, 2019 at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(10,569,502)	(6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(2,813,659)	(2,813,659)
December 31, 2020 at Sep. 30, 2021	$ 4	$ 25	$ 20	$ 20	$ 97	4,454,592	(13,383,162)	(8,928,404)
Balance, shares at Sep. 30, 2021	40,000	246,543	200,000	196,522	972,614
December 31, 2020 at Sep. 30, 2021	$ 4	$ 25	$ 20	$ 20	$ 97	$ 4,454,592	$ (13,383,162)	$ (8,928,404)
Balance, shares at Sep. 30, 2021	40,000	246,543	200,000	196,522	972,614

Balance Sheet (Unaudited)

Balance Sheet (Unaudited) - USD ($)	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 207,921	$ 4,458	$ 52,096
Prepaid expense	295,000	100,000
Total current assets	502,921	104,458	52,096
Total assets	502,921	104,458	52,096
Current liabilities:
Accrued liabilities	162,221	466,801	271,621
Accrued interest	834,910	2,372,072	1,018,145
Convertible notes	635,714	1,956,922	1,486,067
Total current liabilities	3,222,183	8,351,979	3,829,441
Total liabilities	3,222,183	8,351,979	3,829,441
Preferred Stock value	425	413	413
Common stock, par value $0.0001, 2,000,000,000 shares authorized; 1,211,495,162 and 770,883,602 shares issued and outstanding, respectively	137,275	121,149	77,088
Additional paid in capital	10,548,671	8,386,593	8,099,346
Accumulated deficit	(13,405,633)	(16,755,676)	(12,201,899)
Total stockholders’ deficit	(2,719,262)	(8,247,521)	(3,777,345)
Total Liabilities and Stockholders’ Deficit	502,921	104,458	52,096
Stage It Corp [Member]
Current assets:
Cash and cash equivalents	69,342	281,003	88,457
Prepaid expense	1,854		1,288
Other assets		127,874	118,795
Total current assets	71,196	408,877	208,540
Fixed assets -net	60,303	62,912
Total assets	131,499	471,789	208,540
Current liabilities:
Accounts payable	599,817	427,087	223,795
Accrued liabilities	2,313,671	1,785,861	699,914
Accrued interest	840,197	650,654	502,916
Accrued interest -related party	893,632	767,715	617,891
Notes payable	879,922	179,000
Convertible notes -related party	547,500	547,500	547,500
Convertible notes	315,000	315,000	315,000
Derivative liability	2,670,163	2,404,981
Total current liabilities	9,059,902	7,077,798	5,185,041
Total liabilities	9,059,902	7,077,798	5,185,041
Commitments and contingencies
Common stock, par value $0.0001, 2,000,000,000 shares authorized; 1,211,495,162 and 770,883,602 shares issued and outstanding, respectively	97	97	97
Additional paid in capital	4,454,592	3,963,327	3,963,327
Accumulated deficit	(13,383,161)	(10,569,502)	(8,939,994)
Total stockholders’ deficit	(8,928,404)	(6,606,009)	(4,976,502)
Total Liabilities and Stockholders’ Deficit	131,499	471,789	208,540
Stage It Corp [Member] | Preferred Stock A [Member]
Current liabilities:
Preferred Stock value	4	4	4
Stage It Corp [Member] | Preferred Stock A 1 [Member]
Current liabilities:
Preferred Stock value	25	25	25
Stage It Corp [Member] | Preferred Stock A 2 [Member]
Current liabilities:
Preferred Stock value	20	20	20
Stage It Corp [Member] | Preferred Stock A 3 [Member]
Current liabilities:
Preferred Stock value	$ 20	$ 20	$ 20

Balance Sheet (Unaudited) (Pare

Balance Sheet (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	20,000,000	20,000,000	20,000,000
Preferred stock, shares issued	4,250,579	4,126,776	4,126,776
Preferred stock, shares outstanding	4,250,579	4,126,776	4,126,776
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares issued	1,372,757,161	1,211,495,162	770,883,602
Common stock, shares outstanding	1,372,757,161	1,211,495,162	770,883,602
Stage It Corp [Member]
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000	20,000,000
Common stock, shares issued	972,614	972,614	972,614
Common stock, shares outstanding	972,614	972,614	972,614
Preferred Stock A [Member] | Stage It Corp [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	400,000	400,000	400,000
Preferred stock, shares issued	40,000	40,000	40,000
Preferred stock, shares outstanding	40,000	40,000	40,000
Preferred Stock A 1 [Member] | Stage It Corp [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	3,000,000	3,000,000	3,000,000
Preferred stock, shares issued	246,543	246,543	246,543
Preferred stock, shares outstanding	246,543	246,543	246,543
Preferred Stock A 2 [Member] | Stage It Corp [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	2,000,000	2,000,000	2,000,000
Preferred stock, shares issued	200,000	200,000	200,000
Preferred stock, shares outstanding	200,000	200,000	200,000
Preferred Stock A 3 [Member] | Stage It Corp [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	300,000	300,000	300,000
Preferred stock, shares issued	196,522	196,522	196,522
Preferred stock, shares outstanding	196,522	196,522	196,522

Statements of Operation (Unaudi

Statements of Operation (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
General and administrative expenses	$ 279,884		$ 106,990		$ 614,796	$ 477,021	$ 601,022	$ 1,177,756
Operating loss	(282,550)		(105,244)		(610,947)	(465,598)	(587,058)	(1,327,427)
Other income (expense)
Interest expense							(15,630)	(5,630)
Other income (expense), net							(3,966,719)	(72,671)
Net income (loss)	$ (365,161)	$ 1,724,104	$ (6,874,231)	$ (639,557)	$ 3,350,043	$ (7,372,653)	$ (4,553,777)	$ (1,400,098)
Basic and diluted earnings (loss) per common share	$ 0		$ (0.01)		$ 0	$ (0.01)	$ 0	$ 0
Weighted-average number of common shares outstanding:
Basic and diluted	1,341,926,621		1,150,881,152		1,266,155,076	1,070,105,622	1,135,193,463	447,194,161
Stage It Corp [Member]
Revenue-net					$ 313,811	$ 895,145	$ 890,846	$ (4,809)
Operating expenses:
General and administrative expenses					212,728	122,032	231,340	51,764
Contractor expenses					259,686	242,963	455,028	1,805
Payroll expense					1,320,436	658,317	1,142,057	41,331
Stock-based compensation					491,265
Legal and professional fees					114,150	36,365	88,411
Total operating expenses					2,398,265	1,059,677	1,916,836	94,900
Operating loss					(2,084,454)	(164,532)	(1,025,990)	(99,709)
Other income (expense)
Change in derivative liability					(265,182)	(229,467)	(305,956)	(2,099,025)
Interest expense					(464,023)	(223,172)	(297,562)	(257,289)
Other income (expense), net					(729,205)	(452,639)	(603,518)	(2,356,314)
Net income (loss)					$ (2,813,659)	$ (617,171)	$ (1,629,508)	$ (2,456,023)
Basic and diluted earnings (loss) per common share					$ (2.89)	$ (0.63)	$ (1.68)	$ (2.53)
Weighted-average number of common shares outstanding:
Basic and diluted					972,614	972,614	972,614	972,614

Statement of Cash Flows (Unaudi

Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net loss	$ 3,350,043	$ (7,372,653)	$ (4,553,777)	$ (1,400,098)
Change in balance sheet accounts
Prepaid expenses	(195,000)	(100,000)	(100,000)	666
Accrued liabilities	30,000	78,000	100,500	68,000
Derivative liability			2,234,073	(1,179,556)
Net cash (used in) operating activities	(913,466)	(422,722)	(518,493)	(501,905)
Cash flows from investing activities
Net cash provided by investing activities			470,855	535,810
Cash flows from financing activities:
Proceeds from notes payable				25,000
Net cash provided by investing activities	1,116,929	381,855
Net Increase (Decrease) In Cash	203,463	(40,867)	(47,638)	33,905
Cash At The Beginning Of The Period	4,458	52,096	52,096	18,191
Cash At The End Of The Period	207,921	11,229	4,458	52,096
Stage It Corp [Member]
Cash flows from operating activities
Net loss	(2,813,659)	(617,171)	(1,629,508)	(2,456,023)
Depreciation	17,767		4,468
Stock based compensation	491,265
Change in balance sheet accounts
Prepaid expenses	(1,854)	(2,480)	1,288	(1,288)
Other assets	127,874	(75,038)	(9,079)	(21,834)
Accounts payable	172,729	195,210	203,292	13,795
Accrued liabilities	527,811	729,760	297,562	257,289
Accrued interest	315,460	223,172
Derivative liability	265,182	229,467	305,956	2,099,025
Net cash (used in) operating activities	(897,425)	682,920	259,926	(10,506)
Cash flows from investing activities
Purchase of fixed assets	(15,157)	(21,789)
Net cash provided by investing activities	(15,157)	(21,789)	(67,380)
Cash flows from financing activities:
Proceeds from notes payable	700,922
Net cash provided by investing activities	700,922
Net Increase (Decrease) In Cash	(211,660)	661,131	192,546	(10,506)
Cash At The Beginning Of The Period	281,003	88,457	88,457	98,963
Cash At The End Of The Period	69,342	749,588	281,003	88,457
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes

Statement of Changes in Stockho

Statement of Changes in Stockholders' Equity (Unaudited) - Stage It Corp [Member] - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series A One [Member]	Preferred Stock Series A Two [Member]	Preferred Stock Series A Three [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total [Member]
Balance - December 31, 2019 at Dec. 31, 2018	$ 4	$ 25	$ 20	$ 20	$ 97	$ 3,963,327	$ (6,483,971)	$ (2,520,478)
Balance, shares at Dec. 31, 2018	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(2,456,023)	(2,456,023)
December 31, 2020 at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Balance - December 31, 2019 at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(617,171)	(617,171)
December 31, 2020 at Sep. 30, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(9,557,166)	(5,593,672)
Balance, shares at Sep. 30, 2020	40,000	246,543	200,000	196,522	972,614
Balance - December 31, 2019 at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(1,629,508)	(1,629,508)
December 31, 2020 at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(10,569,502)	(6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614
December 31, 2020 at Sep. 30, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(9,557,166)	(5,593,672)
Balance, shares at Sep. 30, 2020	40,000	246,543	200,000	196,522	972,614
Balance - December 31, 2019 at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(10,569,502)	(6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(2,813,659)	(2,813,659)
Stock based compensation						491,265		491,265
December 31, 2020 at Sep. 30, 2021	$ 4	$ 25	$ 20	$ 20	$ 97	4,454,592	(13,383,162)	(8,928,404)
Balance, shares at Sep. 30, 2021	40,000	246,543	200,000	196,522	972,614
December 31, 2020 at Sep. 30, 2021	$ 4	$ 25	$ 20	$ 20	$ 97	$ 4,454,592	$ (13,383,162)	$ (8,928,404)
Balance, shares at Sep. 30, 2021	40,000	246,543	200,000	196,522	972,614

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization VNUE, Inc. (formerly Tierra Grande Resources, Inc.) (“VNUE” or the “Company”) was incorporated under the laws of the State of Nevada on April 4, 2006. On May 29, 2015, VNUE, Inc., known as Tierra Grande Resources, Inc. at the time, entered into a merger agreement with VNUE, Inc., a Washington corporation (VNUE Washington), and TGRI Merger Corp., a Nevada corporation and a wholly-owned subsidiary of VNUE, Inc. (“Merger Sub”). Pursuant to the terms of the Merger Agreement, VNUE Washington merged with and into Merger Sub, with Merger Sub continuing as the surviving entity that succeeded to all of the assets, liabilities and operations of VNUE Washington (the “Merger”). In connection with the Merger, all of the outstanding shares of any class or series of VNUE Washington were exchanged for an aggregate of 50,762,987 The Company is developing technology driven solutions for Artists, Venues and Festivals to automate the capturing, publishing, and monetization of their content, as well as protection of their rights. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the nine months ended September 30, 2021, the Company used cash in operations of $ 913,466 2,719,262 2,719,262 On September 30, 2021, the Company had cash on hand of $ 207,921 On June 22, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with GHS Investments, LLC (the “Purchaser”), a Nevada limited liability company, pursuant to which the Company will have the right in its sole discretion for a period of one year from the date of the SPA, to sell up to $8 million of Common Stock (subject to certain limitations) to GHS Investments. The transaction is considered an Equity Line of Credit (“ELOC”) During the three months ended September 30, 2021, the Company raised $ 722,215 207,921 Management’s Representation of Interim Financial Statements The accompanying unaudited condensed consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto at December 31, 2020, as presented in the Company’s Annual Report on Form 10-K filed on April 8, 2021 with the SEC.	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization VNUE, Inc. (formerly Tierra Grande Resources, Inc.) (“VNUE”, “TGRI”, or the “Company”) was incorporated under the laws of the State of Nevada on April 4, 2006. On May 29, 2015, VNUE, Inc. entered into a merger agreement with VNUE Washington, Inc. Pursuant to the terms of the Merger Agreement, all of the outstanding shares of any class or series of VNUE Washington were exchanged for an aggregate of 50,762,987 shares of TGRI common stock. As a result of the Merger, VNUE Washington became a wholly-owned subsidiary of the Company, and the transaction was accounted for as a reverse merger with VNUE Washington deemed the acquiring company for accounting purposes, and the Company deemed the legal acquirer. The Company is developing technology driven solutions for Artists, Venues and Festivals to automate the capturing, publishing, and monetization of their content, as well as protection of their rights. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the year ended December 31, 2020 the Company incurred a net operating loss of $ 4,553,777 518,493 16,755,676 8,247,522 On December 31, 2020, the Company had cash on hand of $ 4,458 150,000
Stage It Corp [Member]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization Stage It Corp. (“Stage It”, or the “Company”) is a Delaware corporation formed in that operates an online venue for live an interactive performances through its technology platform that enables content creators to perform and create ticketed events, and provides fans with an opportunity to watch live shows, and ask artists questions and request songs. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, during the nine months ended September 30, 2021 the Company incurred a net loss of $ 2,813,659 8,988,706 On As of September 30, 2021, the Company had cash on hand of $ 69,342	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization Stage It Corp. (“Stage It”, or the “Company”) is a Delaware corporation formed in that operates an online venue for live an interactive performances through its technology platform that enables content creators to perform and create ticketed events, and provides fans with an opportunity to watch live shows, and ask artists questions and request songs. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, during the year ended December 31, 2020 the Company incurred a net loss of $ 1,629,508 6,668,922 On December 31, 2020, the Company had cash on hand of $ 281,033

SIGNIFICANT AND CRITICAL ACCOUN

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	NOTE 2 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Consolidation The Company consolidates all wholly-owned subsidiaries in which the Company’s power to control exists. The Company consolidates the following subsidiaries and/or entities: Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 % Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts The Company recognizes revenue on the sale CDs and USB drives that contain the recording of live concerts and made available to concert attendees immediately after the show and on-line. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for impairment testing of intangible assets, assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: • Level 1 — Quoted prices in active markets for identical assets or liabilities. • Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $-0- and $ 3,156,582 Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised, and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2021, because their impact was anti-dilutive. As of September 30, 2021, the Company had outstanding warrants to purchase 15,800,319 11,100,841 Recently Issued Accounting Pronouncements On Dec. 18, 2019, the Financial Accounting Standards Board (FASB) released Accounting Standards Update (ASU) 2019-12, which affects general principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. The FASB has stated that the ASU is being issued as part of its Simplification Initiative, which is meant to reduce complexity in accounting standards by improving certain areas of generally accepted accounting principles (GAAP) without compromising information provided to users of financial statements. The Company adopted this guidance on January 1, 2021 which had no impact on the Company’s financial statements. The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations. The Company adopted ASC 842 on January 1, 2019. However, the adoption of the standard had no impact on the Company’s financial statements since all Company leases are month to month, or short-term rentals.	NOTE 2 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Consolidation The Company consolidates all wholly-owned and majority-owned subsidiaries in which the Company’s power to control exists. The Company consolidates the following subsidiaries and/or entities: Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 % Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts The Company recognizes revenue on the sale CDs and USB drives that contain the recording of live concerts and made available to concert attendees immediately after the show and on-line. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for impairment testing of intangible assets, assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 3,156,582 922,509 Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on December 31, 2020, because their impact was anti-dilutive. As of December 31, 2020, the Company had 23,805,027 1,948,265,842 Intangible Assets The Company accounts for intangible assets in accordance with the authoritative guidance issued by the FASB. Intangibles are valued at their fair market value and are amortized taking into account the character of the acquired intangible asset and the expected period of benefit. The Company evaluates intangible assets for impairment, at a minimum, on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable from its estimated undiscounted future cash flows. Recoverability of intangible assets is measured by comparing their net book value to the related projected undiscounted cash flows from these assets, considering a number of factors, including past operating results, budgets, economic projections, market trends, and product development cycles. If the net book value of the asset exceeds the related undiscounted cash flows, the asset is considered impaired, and a second test is performed to measure the amount of impairment loss. As of December 31, 2020 based on the assessment of Management, the Company determined that its intangible asset had been impaired. Segments The Company operates in one segment for the manufacture and distribution of our products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing, and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements. Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations. The Company adopted ASC 842 on January 1, 2019. However, the adoption of the standard had no impact on the Company’s financial statements since all Company leases are month to month, or short-term rentals.
Stage It Corp [Member]
SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	NOTE 2 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are expressed in United States dollars. For the periods ended September 30, 2021 and December 31, 2020 the financial statements include the accounts of the Company, Stage It. Corporation. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Management’s Representation of Interim Financial Statements The accompanying unaudited financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These financial statements should be read in conjunction with the audited financial statements and notes thereto at December 31, 2020. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 2,670,163 2,404,091 Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 1,000 Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7 As of September 30, 2021 and December 31, 2020 the Company’s property which consisted solely of computers amounted to $ 60,303 62,912 17,767 Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options and, preferred stock and convertible notes. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2021 and December 31, 2020 respectively, because their impact was anti-dilutive. Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.	NOTE 2 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are expressed in United States dollars. For the years ended December 31, 2020 and 2019, the financial statements include the accounts of the Company, Stage It. Corporation Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 2,404,981 2,099,025 Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 1,000 Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7 As of December 31, 2020 and 2019, the Company’s property, which consisted solely of computers, amounted to $ 62,912 0 4,468 0 Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, which could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options and, preferred stock and convertible notes. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on December 31, 2020 and 2019, respectively, because their impact was anti-dilutive. Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.

PREPAID EXPENSE

PREPAID EXPENSE	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSE	NOTE 3 – PREPAID EXPENSE On Jan 9, 2020, the Company entered into an agreement with recording and performance artist, Matchbox Twenty, to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales, to Matchbox Twenty and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020.	NOTE 3 – PREPAID EXPENSE On Jan 9th, 2020, the Company entered into an agreement with recording and performance artist, Matchbox Twenty “MT Agreement”), to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales, to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4th. We have recorded this amount as a prepaid expense on our consolidated balance sheet as of December 31, 2020.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
RELATED PARTY TRANSACTIONS	NOTE 4 – RELATED PARTY TRANSACTIONS DiscLive Network On July 10, 2017, the Company entered into a Licensing Agreement with RockHouse Live Media Productions, Inc., DBA “DiscLive” or “DiscLive Network” (“DiscLive”) to formalize the terms of the Strategic Alliance entered into by the Company with DiscLive on July 21, 2016. VNUE has acquired an exclusive license from DiscLive for a period of three years unless earlier terminated under the Agreement, for the use of all its assets, including but not limited to the DiscLive brand, website (including eCommerce platform), intellectual property, inventory, equipment, trade secrets and anything related to its business of “instant live” recording. Under the terms of the Agreement, DiscLive granted the Company a worldwide exclusive license. In exchange for the license, DiscLive will receive a license fee equal to five percent (5%) of any sales derived from the sale and use of the products and services. DiscLive is controlled by our Chief Executive Officer, Mr. Bair. On March 19, 2021, the Licensing Agreement was extended until March 2022, and will automatically extend unless either party notifies the other of cancellation. Revenues of $ 2,714 9,295 1,746 19,932 136 465 Accrued Payroll to Officers Accrued payroll to officers was $ 239,750 209,750 170,000 Advances from Officers/Stockholders From time to time, officers/stockholders of the Company advance funds to the Company for working capital purposes. During the year ended December 31, 2019, a former employee and stockholder agreed to forgive $ 14,000 14,000 720	NOTE 4 – RELATED PARTY TRANSACTIONS DiscLive Network On July 10, 2017, the Company entered into a Licensing Agreement with RockHouse Live Media Productions, Inc., DBA “DiscLive” or “DiscLive Network” (“DiscLive”) to formalize the terms of the Strategic Alliance entered into by the Company with DiscLive on July 21, 2016. VNUE has acquired an exclusive license from DiscLive, for a period of three years unless earlier terminated under the Agreement, for the use of all its assets, including but not limited to the DiscLive brand, website (including eCommerce platform), intellectual property, inventory, equipment, trade secrets and anything related to its business of “instant live” recording. Under the terms of the Agreement, DiscLive granted the Company a worldwide exclusive license. In exchange for the license, DiscLive will receive a license fee equal to five percent (5%) of any sales derived from the sale and use of the products and services. DiscLive is controlled by our Chief Executive Officer. Revenues of $ 22,474 206,161 8,509 211,031 1,124 10,308 Accrued Payroll to Officers Accrued payroll to officers was $ 209,750 68,000 52,700 15,057,143 40,654 52,700 40,654 12,046 The Chief Executive Officers’ compensation is $ 170,000 129,500 102,000 108,500 68,000 Advances from Officers/Stockholders From time to time, officers/stockholders of the Company advance funds to the Company for working capital purposes. During the year ended December 31, 2019, a former employee and stockholder agreed to forgive $ 14,000 14,000 720 Transactions with Former Director and Officer On September 15, 2017, the Company entered into an Advisory Agreement with Louis Mann (“MANN”), a former officer and director with the Company who previously resigned as an officer and director on August 26, 2015 after a short stint. He was re-appointed to the board on June 23, 2018, while continuing to serve in under the Advisory agreement. The Advisory Agreement provides for MANN’s continued and ongoing advisory services to the Company for nine (9) months and with automatic nine (9) months renewals unless terminated per the agreement. MANN is to receive $5,000 per month and 20,000 shares of common stock per month. Mann is still currently still engaged with the company, and serves as Executive Vice President as well as Director, as noted above. As of December 31, 2018, $ 40,000 40,000 11,428,571 0.0035 9,143 During the year ended December 31, 2019, the Company recorded $ 45,000 41,250 748,429 During the year ended December 31, 2020, $ 60,000
Stage It Corp [Member]
RELATED PARTY TRANSACTIONS	NOTE 3 – RELATED PARTY TRANSACTIONS The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with Evan Lowenstein the company founder and Director, Jaron Lowenstein the brother of Evan, Chuck Lowenstein the father of Evan. The Company also entered into several convertible promissory notes with Robert Jennings over the same period who is a Stage It Director. These notes were issued to fund the early growth of the Company. The notes were issued at 18 547,500 547,500 893,632 767,515	NOTE 3 – RELATED PARTY TRANSACTIONS The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with Evan Lowenstein the company founder and Director, Jaron Lowenstein the brother of Evan, Chuck Lowenstein the father of Evan. The company also entered into several convertible promissory notes with Robert Jennings over the same period who is a Stage It Director. These notes were issued to fund the early growth of the Company. The notes were issued at 18 547,500 547,500 767,715 617,891

NOTE 5 _ ACCOUNTS PAYABLE AND A

NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on September 30, 2021 and December 31, 2020. Schedule of accrued liabilities 9/30/21 12/31/20 Accounts payable and accrued expense $ 527,430 587,230 Accrued interest 162,221 466,801 Accrued interest and penalties Golock (a) - 1,172,782 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities $ 834,910 2,372,072 (a) See Note 9 related to the reversal of interest and penalties for Golock.	NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on December 31, 2020, and December 31, 2019. Schedule of accrued liabilities December 31, December 31, Accounts payable and accrued expense (includes $41,250 to a former officer and director at December 31, 2019, Note 4) $ 587,230 577,115 Accrued interest 466,801 271,621 Accrued interest and penalties Golock(a) 1,172,782 - Soundstr Obligation 145,259 169,409 Total accounts payable and accrued liabilities $ 2,372,072 1,018,145 (a) The Company strongly disagrees with the accrued interest and penalties claimed by Golock in regard to their notes, and intends to arbitrate or litigate this amount if a settlement on a vastly reduced amount cannot be reached.

PURCHASE LIABILITY

PURCHASE LIABILITY	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
PURCHASE LIABILITY	NOTE 6 – PURCHASE LIABILITY On October 16, 2017, the Company entered into an agreement with PledgeMusic, Inc. (the “Seller”), whereby the Company acquired the digital live music distribution platform “Set.fm” from PledgeMusic. The purchase price for the acquisition was comprised of $ 50,000 300,000 350,000 350,000 116,668 204,165 The Company has had no correspondence regarding this liability with Pledge Music who declared bankruptcy in 2019.	NOTE 6 – PURCHASE LIABILITY On October 16, 2017, the Company entered into an agreement with PledgeMusic, Inc. (the “Seller”), whereby the Company acquired the digital live music distribution platform “Set.fm” from PledgeMusic.The purchase price for the acquisition was comprised of $ 50,000 300,000 350,000 350,000 116,668 204,165 300,000

SHARES TO BE ISSUED

SHARES TO BE ISSUED	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Shares To Be Issued
SHARES TO BE ISSUED	NOTE 7 – SHARES TO BE ISSUED As of December 31, 2018, the Company had not yet issued 3,964,352 shares of common stock with a value of $243,839 for past services provided and for an acquisition. During the year ended December 31, 2019, the Company became obligated to issue an additional 240,000 184 1,000,000 3,500 5,204,352 247,707	NOTE 7 – SHARES TO BE ISSUED As of December 31, 2018, the Company had not yet issued 3,964,352 shares of common stock with a value of $243,839 for past services provided and for an acquisition. During the year ended December 31, 2019 the Company became obligated to issue an additional 240,000 184 1,000,000 3,500 5,204,352 247,707

NOTES PAYABLE -PAST DUE

NOTES PAYABLE -PAST DUE	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
NOTES PAYABLE -PAST DUE	NOTE 8 – NOTES PAYABLE -PAST DUE On December 17, 2015, the Company issued a Promissory Note in the principal amount of $ 9,000 the Company receiving notice of the effectiveness of its Form S-1 filed on February 22, 2016. Failure to make payment during that 10-business day period shall constitute an Event of Default, as a result of which the note will become immediately due and payable, and the balance will bear interest at 7%. The Company’s Form S-1 was declared effective on March 8, 2016, and payment was due before March 22, 2016. The Company did not repay the note before March 22, 2016 7 On April 30, 2019, the Company issued an unsecured Promissory Note in the principal amount of $ 25,000 August 30, 2019 5,000 As of September 30, 2021, the accrued interest expense on these two Notes amounted to $ 34,246 The principal balance of the Notes Payable outstanding was $ 22,000 34,000	NOTE 8 – NOTES PAYABLE -PAST DUE On December 17, 2015, the Company issued a Promissory Note in the principal amount of $9,000. The note was due within 10 business days of the Company receiving notice of the effectiveness of its Form S-1 filed on February 22, 2016. Failure to make payment during that 10 business day period shall constitute an Event of Default, as a result of which the note will become immediately due and payable and the balance will bear interest at 7%. The Company’s Form S-1 was declared effective on March 8, 2016, and payment was due before March 22, 2016. The Company did not repay the note before March 22, 2016; therefore, the note is in default with an interest rate of 7%. On April 30, 2019, the Company issued an unsecured Promissory Note in the principal amount of $ 25,000 5,000 During the years ended December 31, 2020 and 2019; the Company recorded $ 15,630 5,630 The balance of the Notes Payable outstanding was $ 34,000 9,000
Stage It Corp [Member]
NOTES PAYABLE -PAST DUE		NOTE 5 – NOTES PAYABLE -PAST DUE As of December 31, 2020 and 2019 the Company had $ 179,000 547,500 315,000 18 275,000 10

CONVERTIBLE NOTES PAYABLE AND N

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIE	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIE	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE RELATED PARTIES Convertible notes payable consists of the following: Schedule of Convertible notes payable September 30, December 31, 2021 2020 Various Convertible Notes (a)(f) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,010 339,011 GSH Note (d) 165,000 - Other Convertible Notes (e) 88,204 238,203 Convertible notes $ 635,714 $ 1,956,922 Notes payable (b)(f) On September 24, 2021, the Company and its largest creditor, Ylimit, agreed to restructure its existing 10% convertible note of $ 492,528 364,629 8 107,000 857,157 857,157 Advance from officer During the three month ended September 30, 2021, the Company’s CEO advanced $ 10,000 10,000 Convertible notes During the three months ended June 30, 2021 the Company converted major portions of its convertible debt to equity. The Company converted $ 1,162,800 38,616 75,195,174 80,227 (a) In August 2014, the Company issued a series of convertible notes with various interest rates ranging up to 10% per annum. The balance of the notes outstanding was $ 43,500 28,500 718,945 (b) On November 9, 2019 the Company and Ylimit, LLC entered into an amendment (“Ylimit Amendment One”) to the original secured convertible promissory note dated May 9, 2016 along with subsequent amendment and fundings that followed. Under the terms of Ylimit Amendment One, Ylimit extended maturity date of all outstanding convertible debt due to them by the company, to a new maturity date of February 09, 2020. Ylimit received no consideration for this amendment. By verbal agreement Ylimit increased the Company’s borrowing limits by $ 175,000 882,500 On February 9, 2020, the Company entered into another amendment with Ylimit (“Ylimit Amendment Two”) to further extend the maturity date of all of the Company’s outstanding debt to August 9, 2020 including the $ 175,000 On January 5, 2021 the Company entered into Amendment Three to extend the maturity of all notes until February 9, 2022. Ylimit received no consideration for Amendment Three. During the nine months ended September 30, 2021, Ylimit invested another $ 119,000 844,844,575 (c) From September 1, 2017 to December 31, 2017, the Company issued convertible notes to Golock Capital, LLC (“Lender”) in the aggregate principal amount of $ 191,750 10 0.015 4,804,708 0.014 191,750 19,652 On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 5,000 2,500,000 40,000 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. 53,331 23,102 100,000,000 339,010 285,679 339,011 As a result Golock has assessed the Company additional penalties and interest of $ 1,172,782 (d) During the nine months ended September 30, 2021, GHS Investments funded an 8%, $ 165,000 171 106,765 (e) As of December 31, 2017 the Company had an outstanding convertible note payable of $ 61,000 369,250 As of September 30, 2021, $ 73,204 16,981,339 Summary The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations.	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIE Convertible notes payable consist of the following: Schedule of Convertible notes payable December 31, December 31, 2020 2019 Various Convertible Notes(a) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) 1,336,208 882,500 Golock Capital, LLC Convertible Notes(c) 339,011 339,011 Other Convertible Notes(d) 238,203 299,069 Total Convertible Notes 1,956,922 1,564,080 Debt discount - (78,013 ) Convertible notes, net $ 1,956,922 $ 1,486,067 (a) In August 2014, the Company issued a series of convertible notes with various interest rates ranging up to 10% per annum. The Note Conversion Price is determined as follows: (a) if the Note is converted upon the Next Equity Financing, an amount equal to 80% of the price paid per share paid by the investors in the Next Equity Financing; (b) if the Note is converted in the event of a Corporate Transaction, a price per share derived by dividing a “pre-money” valuation of $8,000,000 by the number of shares outstanding immediately prior to the time of such conversion, on a fully diluted basis 45,000 1,500 43,500 28,500 (b) On May 9, 2016, the Company issued a convertible note to YLimit, LLC in the principal amount of $ 100,000 10 517,000 517,000 137,358 On April 12, 2018, and again on August 15, 2018, the Company and Ylimit, LLC entered into an amendment to the original secured convertible promissory note. The amendments increased the borrowing limits by $ 190,500 707,500 135,900 190,500 707,500 70,078 On November 9, 2019 the Company and Ylimit, LLC entered into an amendment (“Ylimit Amendment One”) to the original secured convertible promissory note dated May 9, 2016 along with subsequent amendment and fundings that followed. Under the terms of Ylimit Amendment One, Ylimit extended maturity date of all outstanding convertible debt due to them by the company, to a new maturity date of February 09, 2020. Ylimit received no consideration for this amendment. By verbal agreement Ylimit increased the Company’s borrowing limits by $ 175,000 882,500 On February 9, 2020, the Company entered into another amendment with Ylimit (“Ylimit Amendment Two”) to further extend the maturity date of all of the Company’s outstanding debt to August 9, 2020 including the $ 175,000 During the year ended December 31, 2020, Ylimit provided another $ 453,708 1,366,208 (c) From September 1, 2017 to December 31, 2017, the Company issued convertible notes to Golock Capital, LLC (“Lender”) in the aggregate principal amount of $ 191,750 10 4,804,708 0.014 191,750 19,652 On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 10 5,000 0.015 40,000 0.015 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ending December 31, 2019 the Company issued new notes payable of $53,331 and $23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019, was $339,010. As of December 31, 2019, $285,679 of these notes were past due. As of December 31, 2020 all of the Golock notes amounting to $339,011 were past due. As a result Golock has assessed the Company additional penalties and interest pf $1,172,782. The Company has recorded this amount as an accrued liability as of December 1, 2020. The Company disagrees with the accrued interest and penalties due to Golock and intends to litigate this amount if a settlement on a vastly reduced amount, cannot be reached. (d) As of December 31, 2017 the Company had an outstanding convertible note payable of $ 61,000 369,250 559,397 426,964 179,162 238,303 During the year ended December 31, 2019, the Company entered into additional notes of $ 256,000 357,465 On April 29, 2019, one of the lenders entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, the Company issued (a) a warrant to purchase 2,966,986 shares of the Company’s common stock for a period of 48 months exercisable at a strike price of $.00475 with a fair value of $5,934, and (b) the conversion price of outstanding notes was changed from $.015 to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ended December 31, 2019, convertible notes of $388,207 and accrued interest were converted into 540,276,078 shares of common stock. As of December 31, 2019, the aggregate convertible notes balance to the five lenders was $299,069 and the related debt discount was $ 33,667. As of December 31, 2019, $96,069 of these notes were past due. In total, during 2019 convertible notes and accrued interest aggregating $ 411,309 640,276,078 959,290 548,029 1,564,080 78,013 3,334,494,813 During the year ended December 31, 2020, $ 56,466 8,600 440,111,560 263,609 4,400 Summary On December 31, 2020, the aggregate balance of the fair value of all convertible notes outstanding was 1,956,922 0 1,956,922 620,714 1,948,265,842 The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations. The discount is being amortized using the effective interest rate method over the life of the debt instruments. The balance of the unamortized note discount on December 31, 2017 was $ 198,025 583,750 1,329,389 483,635 845,754 432,419 249,241 During the year ended December 31, 2019, the Company issued $ 484,331 357,465 218,637 138,828 389,793 78,013

DERIVATIVE LIABILITY

DERIVATIVE LIABILITY	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
DERIVATIVE LIABILITY	NOTE 10 – DERIVATIVE LIABILITY The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices of the Notes described in Note 6 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of September 30, 2021, and December 31, 2020, the derivative liabilities were valued using probability weighted option pricing models with the following assumptions: Schedule of derivative liabilities fair value 9/30/21 12/31/20 Exercise Price $ 0.00595 0.007140 $ 0.00015 0.00018 Stock Price .0121 $ 0.0003 Risk-free interest rate 0.06 % 0.06 % Expected volatility 204.20 236 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 0 $ 3,156,582 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future. As of September 30, 2021 and supported by a legal opinion which challenged the original transactions as void and advised the Company not to process any conversion notices from Golock , the Company stopped recording the derivative liability on the Golock convertible notes.	NOTE 10 – DERIVATIVE LIABILITY The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices of the Notes described in Note 6 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of December 31, 2020 and 2019, the derivative liabilities were valued using probability weighted option pricing models with the following assumptions: Schedule of derivative liabilities fair value December 31, 2020 December 31, 2019 Exercise Price $ 0.0015 0.0018 $ 0.00015 0.00018 Stock Price .0114 $ 0.0003 Risk-free interest rate 0.17 % 1.59 % Expected volatility 737.80 236 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 3,156,582 $ 922,509 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future. During the year ended December 31, 2019, the Company recorded derivative liabilities of $ 357,465 189,186 1,179,556
Stage It Corp [Member]
DERIVATIVE LIABILITY	NOTE 6 – DERIVATIVE LIABILITY The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices of the Notes described in Note 3 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of September 30, 2021 and December 31, 2020 the derivative liabilities were valued using probability weighted option pricing models with the following assumptions: Schedule of derivative liabilities September 30, December 31, Exercise Price $ 1.19 $ 1.19 Stock Price $ 1.59 $ 1.59 Risk-free interest rate 0.04 % 0.10 % Expected volatility 110.45 % 94.55 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 2,670,162 $ 2,404,981 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.	NOTE 6 – DERIVATIVE LIABILITY The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices of the Notes described in Note 3 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of December 31, 2020 and 2019, the derivative liabilities were valued using probability weighted option pricing models with the following assumptions: Schedule of derivative liabilities December 31, December 31, Exercise Price $ 1.19 $ 1.19 Stock Price 1.59 $ 1.59 Risk-free interest rate 0.10 % 2.54 % Expected volatility 94.55 % 147.95 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 2,404,981 $ 2,099,025 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
STOCKHOLDERS’ DEFICIT	NOTE 11 – STOCKHOLDERS’ DEFICIT On July 2, 2019, the Company filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Articles of Incorporation (as amended to date, the “Articles of Incorporation”) with the Secretary of State of the State of Nevada. The Charter Amendment increased the Company’s capitalization to 2,000,000,000 5,000,000 Common stock The Company has authorized 2,000,000,000 0.0001 1,372,757,161 1,211,495,162 During the reporting period, the Company agreed with an investor to terminate a common stock purchase agreement and cancellation of a common stock purchase warrant associated with the purchase agreement. The termination was not the result of any disagreement between the Company and the investor. Preferred Stock Series A As of September 30, 2021, and December 31, 2020, the Company had 20,000,000 0.0001 4,250,579 4,126,776 On May 22, 2019, the Company authorized and designated a class of Series A Convertible Preferred Stock (“Series A Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series A Designation”). It subsequently issued 4,126,776 Pursuant to the Series A Designation, each share of Series A Preferred Stock may be converted into 50 shares of common stock of the Company. The Series A Preferred Stockholders shall be entitled to share among dividends with the common stock shareholders of the Company on an as-converted basis. The Series A Preferred Stockholders shall vote with the common stock as a single class, on a 100 to 1 basis, such that for every share of Series A Preferred Stock held, such shares shall entitle the holder to cast 100 votes. The holders of the Series A Preferred Stock have no liquidation or redemption preference rights but get treated as common stockholders on an as converted basis. The Company believes that the issuance of the Series A Preferred Stock was exempt from the registration requirements under the Securities Act of 1933, as amended pursuant to Section 4(a)(2) of the Act in that said transaction did not involve a public solicitation and said restricted shares were issued to only a small number of employees and consultants with an ongoing relationship with the Company. Warrants No warrants were issued during the three ended September 30, 2021. A summary of warrants is as follows: Schedule of warrants Number Weighted of Average Warrants Exercise Balance outstanding, December 31, 2018 8,004,708 0.014 Warrants granted 15,800,319 .00475 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2019 23,805,027 0.079 Warrants granted - - Warrants exercised - - Balance outstanding, December 31, 2020 23,805,027 0.079 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, September 30, 2021 15,800,319 $ 0.0079 Information relating to outstanding warrants on September 30, 2021, summarized by exercise price, is as follows: Schedule of warrants outstanding and related prices Outstanding and Exercisable Weighted Exercise Price Per Average Share Shares Life (Years) Exercise Price $ 0.004750 15,800,319 2.08 $ 0.00475 The weighted-average remaining contractual life of all warrants outstanding and exercisable on September 30, 2021 is 2.08 years. The outstanding and exercisable warrants outstanding on September 30, 2021, had no intrinsic value.	NOTE 11 – STOCKHOLDERS’ DEFICIT On July 2, 2019, the Company filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Articles of Incorporation (as amended to date, the “Articles of Incorporation”) with the Secretary of State of the State of Nevada. The Charter Amendment increased the Company’s capitalization to 2,000,000,000 5,000,000 Common stock The Company has authorized 2,000,000,000 1,211,495,162 Common stock returned by a director or officer During the year ended December 31, 2019, a former Company director voluntarily returned 4,555,918 456 Shares issued for services During the year ended December 31, 2020, the Company issued 500,000 150 During the year ended December 31, 2019, the Company issued 2,500,000 3,368 Shares issued to retire trade debt During the year ended December 31, 2019, the Company reached agreement with a vendor to retire approximately $ 27,096 0.05 541,912 .0013 26,391 Preferred Stock Series A As of December 31, 2020 and 2019, the Company had 20,000,000 0.0001 4,126,776 On May 22, 2019, the Company authorized and designated a class of Series A Convertible Preferred Stock (“Series A Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series A Designation”). It subsequently issued 4,126,776 restricted shares of Series A Preferred Stock to various employees and service providers to compensate and reward them for services and to incentivize them to provide continued service to the Company. The Series A Preferred Stock receives relative rights and preferences under terms and conditions set forth in the Certificate of Designation of the Preferred Stock. Pursuant to the Series A Designation, each share of Series A Preferred Stock may be converted into 50 shares of common stock of the Company. The Series A Preferred Stockholders shall be entitled to share among dividends with the common stock shareholders of the Company on an as-converted basis. The Series A Preferred Stockholders shall vote with the common stock as a single class, on a 100 to 1 basis, such that for every share of Series A Preferred Stock held, such shares shall entitle the holder to cast 100 votes. The holders of the Series A Preferred Stock have no liquidation or redemption preference rights but get treated as common stockholders on an as converted basis. The Company believes that the issuance of the Series A Preferred Stock was exempt from the registration requirements under the Securities Act of 1933, as amended pursuant to Section 4(a)(2) of the Act in that said transaction did not involve a public solicitation and said restricted shares were issued to only a small number of employees and consultants with an ongoing relationship with the Company. The Company determined the fair value of the preferred shares to be $590,129 which is included as stock-based compensation in general and administrative expense on the Company’s statements of operations for the year ended December 31, 2019. Warrants No warrants were issued during the year ended December 31, 2020. During the year ended December 31, 2019, the Company issued 15,800,319 0.00475 36,533 A summary of warrants for the years ended December 31, 2020 and December 31, 2019, is as follows: Schedule of warrants Number Weighted of Average Warrants Exercise Balance outstanding, December 31, 2018 8,004,708 0.014 Warrants granted 15,800,319 .00475 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2019 23,805,027 0.079 Warrants granted - - Warrants exercised - - Warrants expired or forfeited - - Balance outstanding and exercisable, December 31, 2020 23,805,027 $ 0.0079 Information relating to outstanding warrants on December 31, 2020, summarized by exercise price, is as follows: Schedule of warrants outstanding and related prices Outstanding and Exercisable Weighted Exercise Price Average Per Share Shares Life (Years) Exercise Price $ 0.010 0.015 8,004,708 0.14 $ 0.014 $ 0.004750 15,800,319 2.58 $ 0.00475 The weighted-average remaining contractual life of all warrants outstanding and exercisable on December 31, 2020, is .96 years. The outstanding and exercisable warrants outstanding on December 31, 2020, had no intrinsic value.
Stage It Corp [Member]
STOCKHOLDERS’ DEFICIT	NOTE 7 – STOCKHOLDERS’ DEFICIT Common stock The Company has authorized 20,000,000 972,614 Preferred stock As of September 30, 2021 and December 31, 2021, the Company had four classes of non-redeemable Preferred stock $0.0001 Preferred A, Preferred A-1, Preferred A-2, and Preferred A-3, all with a par value of $0.0001. The number of Preferred Shares authorized and issued and outstanding are as follows: Preferred A 400,000 40,000 Preferred A-1 3,000,000 246,543 Preferred A-2 2,000,000 200,000 Preferred A-3 300,000 196,522 Each share of preferred stock is convertible to common stock on a 1 for 1 basis	NOTE 7 – STOCKHOLDERS’ DEFICIT Common stock The Company has authorized 20,000,000 972,614 Preferred stock As of December 31, 2020 and December 19, 2020, the Company had four classes of non-redeemable Preferred stock $ 0.0001 0.0001 Preferred A 400,000 40,000 Preferred A-1 3,000,000 246,543 Preferred A-2 2,000,000 200,000 Preferred A-3 300,000 196,522 Each share of preferred stock is convertible to common stock on a 1 for 1 basis

COMMITMENT AND CONTINGENCIES

COMMITMENT AND CONTINGENCIES	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
COMMITMENT AND CONTINGENCIES	NOTE 12 – COMMITMENT AND CONTINGENCIES Joint Venture Agreement – Music Reports, Inc. On September 1, 2018, the Company entered into an initial joint venture (“JV”) agreement with Music Reports, Inc., (“MRI”). Music Reports (musicreports.com) will initially partner with VNUE to provide Performing Rights Organization (PRO) data to VNUE’s Soundstr MRT (music recognition technology) platform through its extensive Songdex database, and will eventually work with VNUE to integrate automated direct licensing capability and royalty payment and distribution into the Soundstr platform. The initial term of the JV is for nine (6) months and requires the Company to Pay MRI fifty percent (50%) of net revenue every quarter. As of September 30, 2021, no net revenue was generated from the JV. Litigation None	NOTE 12 – COMMITMENT AND CONTINGENCIES Joint Venture Agreement – Music Reports, Inc. On September 1, 2018, the Company entered into an initial joint venture (“JV”) agreement with Music Reports, Inc., (“MRI”). Music Reports (musicreports.com) will initially partner with VNUE to provide Performing Rights Organization (PRO) data to VNUE’s Soundstr MRT (music recognition technology) platform through its extensive Songdex database, and will eventually work with VNUE to integrate automated direct licensing capability and royalty payment and distribution into the Soundstr platform. The initial term of the JV is for nine (6) months and requires the Company to Pay MRI fifty percent (50%) of net revenue every quarter. As of December 31, 2020, no net revenue was generated from the JV. Litigation None Artist Agreement On October 27, 2015, the Company entered into an Artist Agreement with I Break Horses, a Swedish duo based in Stockholm. The Artist Agreement is effective October 27, 2015, and has a term lasting as long as I Break Horses artist recordings are available via the VNUE Service. Under the terms of the Artist Agreement, the Company shall handle rights clearing and distribution for I Break Horses recordings and receive 30% of the Net Income generated thereby. As of December 31, 2020, the Company had not earned any revenue under this agreement.
Stage It Corp [Member]
COMMITMENT AND CONTINGENCIES	NOTE 8 – COMMITMENT AND CONTINGENCIES The Company had no	NOTE 8 – COMMITMENT AND CONTINGENCIES The Company had no

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 13 – INCOME TAXES Reconciliation between the expected federal income tax rate and the actual tax rate is as follows: Schedule of federal income tax rate and the actual tax rate Year Ended 2020 2019 Federal statutory tax rate 21 % 21 % State tax, net of federal benefit 6 % 6 % Total tax rate 27 % 27 % Allowance ( 27 )% ( 27 )% Effective tax rate - % - % The following is a summary of the deferred tax assets: Summary of deferred tax assets Year Ended 2020 2019 Net operating loss carryforwards $ 3,060,000 2,434,000 Accrued compensation - - Deferred tax asset 3,060,000 2,434,000 Valuation allowance (3,060,000 ) (2,434,000 ) Net deferred tax asset $ - $ - The Company has no tax provision for any period presented due to our history of operating losses. As of December 31, 2020, the Company had estimated net operating loss carry forwards of approximately $ 11,333,000 through 2032 The Company adopted accounting rules which address the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under these rules, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. These accounting rules also provide guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. As of December 31, 2017 no liability for unrecognized tax benefits was required to be recorded.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
SUBSEQUENT EVENTS	NOTE 13 – SUBSEQUENT EVENTS During October and November 2021, the Company raised $ 355,884 39,022,336 .0912	NOTE 14 – SUBSEQUENT EVENTS In February 2021, the Company entered into a $ 165,000 8 November 16, 2021 150,000 .0171
Stage It Corp [Member]
SUBSEQUENT EVENTS	NOTE 9 – SUBSEQUENT EVENTS Subsequent to September 30, 2021 the Company received ___________ in proceeds comprised of a On February 13, 2022, the Company entered into an agreement with VNUE, Inc. to sell 100 10,000,000 1,500,000 8,500,000	NOTE 9 – SUBSEQUENT EVENTS Subsequent to December 31, 2020 the Company received $ 700,922 250,000 15 35,000 415,922 On February ______, 2022, the Company entered into an agreement with VNUE, Inc. to sell 100 10,000,000 1,500,000 8,500,000

ACCOUNTS PAYABLE AND ACCRUED LI

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on September 30, 2021 and December 31, 2020. Schedule of accrued liabilities 9/30/21 12/31/20 Accounts payable and accrued expense $ 527,430 587,230 Accrued interest 162,221 466,801 Accrued interest and penalties Golock (a) - 1,172,782 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities $ 834,910 2,372,072 (a) See Note 9 related to the reversal of interest and penalties for Golock.	NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on December 31, 2020, and December 31, 2019. Schedule of accrued liabilities December 31, December 31, Accounts payable and accrued expense (includes $41,250 to a former officer and director at December 31, 2019, Note 4) $ 587,230 577,115 Accrued interest 466,801 271,621 Accrued interest and penalties Golock(a) 1,172,782 - Soundstr Obligation 145,259 169,409 Total accounts payable and accrued liabilities $ 2,372,072 1,018,145 (a) The Company strongly disagrees with the accrued interest and penalties claimed by Golock in regard to their notes, and intends to arbitrate or litigate this amount if a settlement on a vastly reduced amount cannot be reached.
Stage It Corp [Member]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on September 30, 2021, and December 31, 2020. Schedule of accounts payable and accrued liabilities September 30, 2021 December 31, 2020 Accounts payable $ 599,817 $ 427,086 Accrued liabilities (a)(b) 2,313,671 1,785,861 Accrued interest 840,197 650,654 Accrued interest- related parties 893,632 767,715 Total accounts payable and accrued liabilities $ 4,647,317 $ 2,404,981 (a) Includes $887,120 in liabilities due to artists, $846,477 in unredeemed outstanding notes purchased by users, and $376,703 in payroll liabilities as of September 30, 2021 (b) Includes $946,537 in liabilities due to artists and $781,172 in unredeemed outstanding notes purchased by users as of December 31, 2020	NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on December 31, 2020, and December 31, 2019. Schedule of accounts payable and accrued liabilities December 31, December 31, Accounts payable $ 427,086 $ 223,795 Accrued liabilities (a)(b) 1,785,861 699,914 Accrued interest 650,654 502,916 Accrued interest- related parties 767,715 617,891 Total accounts payable and accrued liabilities $ 2,404,981 $ 2,044,516 (a) Includes $946,537 in liabilities due to artists and $791,172 in unredeemed outstanding notes purchased by users as of December 31, 2020 (b) Includes $398,729 in liabilities due to artists and $297,795 in unredeemed outstanding notes purchased by users as of December 31, 2019

CONVERTIBLE NOTES PAYABLE AND_2

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE RELATED PARTIES	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE RELATED PARTIES	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE RELATED PARTIES Convertible notes payable consists of the following: Schedule of Convertible notes payable September 30, December 31, 2021 2020 Various Convertible Notes (a)(f) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,010 339,011 GSH Note (d) 165,000 - Other Convertible Notes (e) 88,204 238,203 Convertible notes $ 635,714 $ 1,956,922 Notes payable (b)(f) On September 24, 2021, the Company and its largest creditor, Ylimit, agreed to restructure its existing 10% convertible note of $ 492,528 364,629 8 107,000 857,157 857,157 Advance from officer During the three month ended September 30, 2021, the Company’s CEO advanced $ 10,000 10,000 Convertible notes During the three months ended June 30, 2021 the Company converted major portions of its convertible debt to equity. The Company converted $ 1,162,800 38,616 75,195,174 80,227 (a) In August 2014, the Company issued a series of convertible notes with various interest rates ranging up to 10% per annum. The balance of the notes outstanding was $ 43,500 28,500 718,945 (b) On November 9, 2019 the Company and Ylimit, LLC entered into an amendment (“Ylimit Amendment One”) to the original secured convertible promissory note dated May 9, 2016 along with subsequent amendment and fundings that followed. Under the terms of Ylimit Amendment One, Ylimit extended maturity date of all outstanding convertible debt due to them by the company, to a new maturity date of February 09, 2020. Ylimit received no consideration for this amendment. By verbal agreement Ylimit increased the Company’s borrowing limits by $ 175,000 882,500 On February 9, 2020, the Company entered into another amendment with Ylimit (“Ylimit Amendment Two”) to further extend the maturity date of all of the Company’s outstanding debt to August 9, 2020 including the $ 175,000 On January 5, 2021 the Company entered into Amendment Three to extend the maturity of all notes until February 9, 2022. Ylimit received no consideration for Amendment Three. During the nine months ended September 30, 2021, Ylimit invested another $ 119,000 844,844,575 (c) From September 1, 2017 to December 31, 2017, the Company issued convertible notes to Golock Capital, LLC (“Lender”) in the aggregate principal amount of $ 191,750 10 0.015 4,804,708 0.014 191,750 19,652 On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 5,000 2,500,000 40,000 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. 53,331 23,102 100,000,000 339,010 285,679 339,011 As a result Golock has assessed the Company additional penalties and interest of $ 1,172,782 (d) During the nine months ended September 30, 2021, GHS Investments funded an 8%, $ 165,000 171 106,765 (e) As of December 31, 2017 the Company had an outstanding convertible note payable of $ 61,000 369,250 As of September 30, 2021, $ 73,204 16,981,339 Summary The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations.	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIE Convertible notes payable consist of the following: Schedule of Convertible notes payable December 31, December 31, 2020 2019 Various Convertible Notes(a) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) 1,336,208 882,500 Golock Capital, LLC Convertible Notes(c) 339,011 339,011 Other Convertible Notes(d) 238,203 299,069 Total Convertible Notes 1,956,922 1,564,080 Debt discount - (78,013 ) Convertible notes, net $ 1,956,922 $ 1,486,067 (a) In August 2014, the Company issued a series of convertible notes with various interest rates ranging up to 10% per annum. The Note Conversion Price is determined as follows: (a) if the Note is converted upon the Next Equity Financing, an amount equal to 80% of the price paid per share paid by the investors in the Next Equity Financing; (b) if the Note is converted in the event of a Corporate Transaction, a price per share derived by dividing a “pre-money” valuation of $8,000,000 by the number of shares outstanding immediately prior to the time of such conversion, on a fully diluted basis 45,000 1,500 43,500 28,500 (b) On May 9, 2016, the Company issued a convertible note to YLimit, LLC in the principal amount of $ 100,000 10 517,000 517,000 137,358 On April 12, 2018, and again on August 15, 2018, the Company and Ylimit, LLC entered into an amendment to the original secured convertible promissory note. The amendments increased the borrowing limits by $ 190,500 707,500 135,900 190,500 707,500 70,078 On November 9, 2019 the Company and Ylimit, LLC entered into an amendment (“Ylimit Amendment One”) to the original secured convertible promissory note dated May 9, 2016 along with subsequent amendment and fundings that followed. Under the terms of Ylimit Amendment One, Ylimit extended maturity date of all outstanding convertible debt due to them by the company, to a new maturity date of February 09, 2020. Ylimit received no consideration for this amendment. By verbal agreement Ylimit increased the Company’s borrowing limits by $ 175,000 882,500 On February 9, 2020, the Company entered into another amendment with Ylimit (“Ylimit Amendment Two”) to further extend the maturity date of all of the Company’s outstanding debt to August 9, 2020 including the $ 175,000 During the year ended December 31, 2020, Ylimit provided another $ 453,708 1,366,208 (c) From September 1, 2017 to December 31, 2017, the Company issued convertible notes to Golock Capital, LLC (“Lender”) in the aggregate principal amount of $ 191,750 10 4,804,708 0.014 191,750 19,652 On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 10 5,000 0.015 40,000 0.015 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ending December 31, 2019 the Company issued new notes payable of $53,331 and $23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019, was $339,010. As of December 31, 2019, $285,679 of these notes were past due. As of December 31, 2020 all of the Golock notes amounting to $339,011 were past due. As a result Golock has assessed the Company additional penalties and interest pf $1,172,782. The Company has recorded this amount as an accrued liability as of December 1, 2020. The Company disagrees with the accrued interest and penalties due to Golock and intends to litigate this amount if a settlement on a vastly reduced amount, cannot be reached. (d) As of December 31, 2017 the Company had an outstanding convertible note payable of $ 61,000 369,250 559,397 426,964 179,162 238,303 During the year ended December 31, 2019, the Company entered into additional notes of $ 256,000 357,465 On April 29, 2019, one of the lenders entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, the Company issued (a) a warrant to purchase 2,966,986 shares of the Company’s common stock for a period of 48 months exercisable at a strike price of $.00475 with a fair value of $5,934, and (b) the conversion price of outstanding notes was changed from $.015 to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ended December 31, 2019, convertible notes of $388,207 and accrued interest were converted into 540,276,078 shares of common stock. As of December 31, 2019, the aggregate convertible notes balance to the five lenders was $299,069 and the related debt discount was $ 33,667. As of December 31, 2019, $96,069 of these notes were past due. In total, during 2019 convertible notes and accrued interest aggregating $ 411,309 640,276,078 959,290 548,029 1,564,080 78,013 3,334,494,813 During the year ended December 31, 2020, $ 56,466 8,600 440,111,560 263,609 4,400 Summary On December 31, 2020, the aggregate balance of the fair value of all convertible notes outstanding was 1,956,922 0 1,956,922 620,714 1,948,265,842 The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations. The discount is being amortized using the effective interest rate method over the life of the debt instruments. The balance of the unamortized note discount on December 31, 2017 was $ 198,025 583,750 1,329,389 483,635 845,754 432,419 249,241 During the year ended December 31, 2019, the Company issued $ 484,331 357,465 218,637 138,828 389,793 78,013

NOTES PAYABLE

NOTES PAYABLE	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
NOTES PAYABLE	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE RELATED PARTIES Convertible notes payable consists of the following: Schedule of Convertible notes payable September 30, December 31, 2021 2020 Various Convertible Notes (a)(f) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,010 339,011 GSH Note (d) 165,000 - Other Convertible Notes (e) 88,204 238,203 Convertible notes $ 635,714 $ 1,956,922 Notes payable (b)(f) On September 24, 2021, the Company and its largest creditor, Ylimit, agreed to restructure its existing 10% convertible note of $ 492,528 364,629 8 107,000 857,157 857,157 Advance from officer During the three month ended September 30, 2021, the Company’s CEO advanced $ 10,000 10,000 Convertible notes During the three months ended June 30, 2021 the Company converted major portions of its convertible debt to equity. The Company converted $ 1,162,800 38,616 75,195,174 80,227 (a) In August 2014, the Company issued a series of convertible notes with various interest rates ranging up to 10% per annum. The balance of the notes outstanding was $ 43,500 28,500 718,945 (b) On November 9, 2019 the Company and Ylimit, LLC entered into an amendment (“Ylimit Amendment One”) to the original secured convertible promissory note dated May 9, 2016 along with subsequent amendment and fundings that followed. Under the terms of Ylimit Amendment One, Ylimit extended maturity date of all outstanding convertible debt due to them by the company, to a new maturity date of February 09, 2020. Ylimit received no consideration for this amendment. By verbal agreement Ylimit increased the Company’s borrowing limits by $ 175,000 882,500 On February 9, 2020, the Company entered into another amendment with Ylimit (“Ylimit Amendment Two”) to further extend the maturity date of all of the Company’s outstanding debt to August 9, 2020 including the $ 175,000 On January 5, 2021 the Company entered into Amendment Three to extend the maturity of all notes until February 9, 2022. Ylimit received no consideration for Amendment Three. During the nine months ended September 30, 2021, Ylimit invested another $ 119,000 844,844,575 (c) From September 1, 2017 to December 31, 2017, the Company issued convertible notes to Golock Capital, LLC (“Lender”) in the aggregate principal amount of $ 191,750 10 0.015 4,804,708 0.014 191,750 19,652 On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 5,000 2,500,000 40,000 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. 53,331 23,102 100,000,000 339,010 285,679 339,011 As a result Golock has assessed the Company additional penalties and interest of $ 1,172,782 (d) During the nine months ended September 30, 2021, GHS Investments funded an 8%, $ 165,000 171 106,765 (e) As of December 31, 2017 the Company had an outstanding convertible note payable of $ 61,000 369,250 As of September 30, 2021, $ 73,204 16,981,339 Summary The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations.	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIE Convertible notes payable consist of the following: Schedule of Convertible notes payable December 31, December 31, 2020 2019 Various Convertible Notes(a) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) 1,336,208 882,500 Golock Capital, LLC Convertible Notes(c) 339,011 339,011 Other Convertible Notes(d) 238,203 299,069 Total Convertible Notes 1,956,922 1,564,080 Debt discount - (78,013 ) Convertible notes, net $ 1,956,922 $ 1,486,067 (a) In August 2014, the Company issued a series of convertible notes with various interest rates ranging up to 10% per annum. The Note Conversion Price is determined as follows: (a) if the Note is converted upon the Next Equity Financing, an amount equal to 80% of the price paid per share paid by the investors in the Next Equity Financing; (b) if the Note is converted in the event of a Corporate Transaction, a price per share derived by dividing a “pre-money” valuation of $8,000,000 by the number of shares outstanding immediately prior to the time of such conversion, on a fully diluted basis 45,000 1,500 43,500 28,500 (b) On May 9, 2016, the Company issued a convertible note to YLimit, LLC in the principal amount of $ 100,000 10 517,000 517,000 137,358 On April 12, 2018, and again on August 15, 2018, the Company and Ylimit, LLC entered into an amendment to the original secured convertible promissory note. The amendments increased the borrowing limits by $ 190,500 707,500 135,900 190,500 707,500 70,078 On November 9, 2019 the Company and Ylimit, LLC entered into an amendment (“Ylimit Amendment One”) to the original secured convertible promissory note dated May 9, 2016 along with subsequent amendment and fundings that followed. Under the terms of Ylimit Amendment One, Ylimit extended maturity date of all outstanding convertible debt due to them by the company, to a new maturity date of February 09, 2020. Ylimit received no consideration for this amendment. By verbal agreement Ylimit increased the Company’s borrowing limits by $ 175,000 882,500 On February 9, 2020, the Company entered into another amendment with Ylimit (“Ylimit Amendment Two”) to further extend the maturity date of all of the Company’s outstanding debt to August 9, 2020 including the $ 175,000 During the year ended December 31, 2020, Ylimit provided another $ 453,708 1,366,208 (c) From September 1, 2017 to December 31, 2017, the Company issued convertible notes to Golock Capital, LLC (“Lender”) in the aggregate principal amount of $ 191,750 10 4,804,708 0.014 191,750 19,652 On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 10 5,000 0.015 40,000 0.015 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ending December 31, 2019 the Company issued new notes payable of $53,331 and $23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019, was $339,010. As of December 31, 2019, $285,679 of these notes were past due. As of December 31, 2020 all of the Golock notes amounting to $339,011 were past due. As a result Golock has assessed the Company additional penalties and interest pf $1,172,782. The Company has recorded this amount as an accrued liability as of December 1, 2020. The Company disagrees with the accrued interest and penalties due to Golock and intends to litigate this amount if a settlement on a vastly reduced amount, cannot be reached. (d) As of December 31, 2017 the Company had an outstanding convertible note payable of $ 61,000 369,250 559,397 426,964 179,162 238,303 During the year ended December 31, 2019, the Company entered into additional notes of $ 256,000 357,465 On April 29, 2019, one of the lenders entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, the Company issued (a) a warrant to purchase 2,966,986 shares of the Company’s common stock for a period of 48 months exercisable at a strike price of $.00475 with a fair value of $5,934, and (b) the conversion price of outstanding notes was changed from $.015 to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ended December 31, 2019, convertible notes of $388,207 and accrued interest were converted into 540,276,078 shares of common stock. As of December 31, 2019, the aggregate convertible notes balance to the five lenders was $299,069 and the related debt discount was $ 33,667. As of December 31, 2019, $96,069 of these notes were past due. In total, during 2019 convertible notes and accrued interest aggregating $ 411,309 640,276,078 959,290 548,029 1,564,080 78,013 3,334,494,813 During the year ended December 31, 2020, $ 56,466 8,600 440,111,560 263,609 4,400 Summary On December 31, 2020, the aggregate balance of the fair value of all convertible notes outstanding was 1,956,922 0 1,956,922 620,714 1,948,265,842 The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations. The discount is being amortized using the effective interest rate method over the life of the debt instruments. The balance of the unamortized note discount on December 31, 2017 was $ 198,025 583,750 1,329,389 483,635 845,754 432,419 249,241 During the year ended December 31, 2019, the Company issued $ 484,331 357,465 218,637 138,828 389,793 78,013
Stage It Corp [Member]
NOTES PAYABLE	NOTE 5 – NOTES PAYABLE The following table sets forth the components of the Company’s notes payable on September 30, 2021, and December 31, 2020. Schedule of notes payable September 30, December 31, Notes payable (a) $ 879,722 $ 179,000 Convertible notes related party-past due (b) 547,500 547,500 Convertible notes-past due (b) 315,000 315,000 Total notes payable $ 1,742,422 $ 1,041,500 (a) Notes payable are comprised of a note for $179,000 at 15% interest in both period that is past due, a promissory note for $250,000 at 15% interest, advances of $35,000, and $415,922 in loans under the terms of revenue factoring agreement with three different lenders at an average rate of _____% (b) The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with several related parties (see Note 3) and third parties. These notes were issued to fund the early growth of the Company. The notes were issued at 18% interest compound annually and can only convert to common stock upon the occurrence of a qualified funding, which has not occurred

SIGNIFICANT AND CRITICAL ACCO_2

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Policies)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Basis of Consolidation	Basis of Consolidation The Company consolidates all wholly-owned subsidiaries in which the Company’s power to control exists. The Company consolidates the following subsidiaries and/or entities: Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 %	Basis of Consolidation The Company consolidates all wholly-owned and majority-owned subsidiaries in which the Company’s power to control exists. The Company consolidates the following subsidiaries and/or entities: Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 %
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts The Company recognizes revenue on the sale CDs and USB drives that contain the recording of live concerts and made available to concert attendees immediately after the show and on-line. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased.	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts The Company recognizes revenue on the sale CDs and USB drives that contain the recording of live concerts and made available to concert attendees immediately after the show and on-line. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for impairment testing of intangible assets, assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.	Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for impairment testing of intangible assets, assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: • Level 1 — Quoted prices in active markets for identical assets or liabilities. • Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $-0- and $ 3,156,582	Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 3,156,582 922,509
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
Income (Loss) per Common Share	Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised, and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2021, because their impact was anti-dilutive. As of September 30, 2021, the Company had outstanding warrants to purchase 15,800,319 11,100,841	Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on December 31, 2020, because their impact was anti-dilutive. As of December 31, 2020, the Company had 23,805,027 1,948,265,842
Intangible Assets		Intangible Assets The Company accounts for intangible assets in accordance with the authoritative guidance issued by the FASB. Intangibles are valued at their fair market value and are amortized taking into account the character of the acquired intangible asset and the expected period of benefit. The Company evaluates intangible assets for impairment, at a minimum, on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable from its estimated undiscounted future cash flows. Recoverability of intangible assets is measured by comparing their net book value to the related projected undiscounted cash flows from these assets, considering a number of factors, including past operating results, budgets, economic projections, market trends, and product development cycles. If the net book value of the asset exceeds the related undiscounted cash flows, the asset is considered impaired, and a second test is performed to measure the amount of impairment loss. As of December 31, 2020 based on the assessment of Management, the Company determined that its intangible asset had been impaired.
Segments		Segments The Company operates in one segment for the manufacture and distribution of our products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing, and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements On Dec. 18, 2019, the Financial Accounting Standards Board (FASB) released Accounting Standards Update (ASU) 2019-12, which affects general principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. The FASB has stated that the ASU is being issued as part of its Simplification Initiative, which is meant to reduce complexity in accounting standards by improving certain areas of generally accepted accounting principles (GAAP) without compromising information provided to users of financial statements. The Company adopted this guidance on January 1, 2021 which had no impact on the Company’s financial statements. The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations. The Company adopted ASC 842 on January 1, 2019. However, the adoption of the standard had no impact on the Company’s financial statements since all Company leases are month to month, or short-term rentals.	Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations. The Company adopted ASC 842 on January 1, 2019. However, the adoption of the standard had no impact on the Company’s financial statements since all Company leases are month to month, or short-term rentals.
Stage It Corp [Member]
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.	Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 2,670,163 2,404,091	Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 2,404,981 2,099,025
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
Income (Loss) per Common Share	Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options and, preferred stock and convertible notes. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2021 and December 31, 2020 respectively, because their impact was anti-dilutive.	Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, which could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options and, preferred stock and convertible notes. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on December 31, 2020 and 2019, respectively, because their impact was anti-dilutive.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.	Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.
Basis of Presentation	Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are expressed in United States dollars. For the periods ended September 30, 2021 and December 31, 2020 the financial statements include the accounts of the Company, Stage It. Corporation.	Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are expressed in United States dollars. For the years ended December 31, 2020 and 2019, the financial statements include the accounts of the Company, Stage It. Corporation
Property and Equipment	Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 1,000 Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7 As of September 30, 2021 and December 31, 2020 the Company’s property which consisted solely of computers amounted to $ 60,303 62,912 17,767	Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 1,000 Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7 As of December 31, 2020 and 2019, the Company’s property, which consisted solely of computers, amounted to $ 62,912 0 4,468 0
Management’s Representation of Interim Financial Statements	Management’s Representation of Interim Financial Statements The accompanying unaudited financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These financial statements should be read in conjunction with the audited financial statements and notes thereto at December 31, 2020.

SIGNIFICANT AND CRITICAL ACCO_3

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Schedule of subsidiaries and/or entities	Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 %	Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 %
Stage It Corp [Member]
Schedule of estimated useful lives	Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7	Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7

NOTE 5 _ ACCOUNTS PAYABLE AND_2

NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Schedule of accrued liabilities	Schedule of accrued liabilities 9/30/21 12/31/20 Accounts payable and accrued expense $ 527,430 587,230 Accrued interest 162,221 466,801 Accrued interest and penalties Golock (a) - 1,172,782 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities $ 834,910 2,372,072 (a) See Note 9 related to the reversal of interest and penalties for Golock.	Schedule of accrued liabilities December 31, December 31, Accounts payable and accrued expense (includes $41,250 to a former officer and director at December 31, 2019, Note 4) $ 587,230 577,115 Accrued interest 466,801 271,621 Accrued interest and penalties Golock(a) 1,172,782 - Soundstr Obligation 145,259 169,409 Total accounts payable and accrued liabilities $ 2,372,072 1,018,145 (a) The Company strongly disagrees with the accrued interest and penalties claimed by Golock in regard to their notes, and intends to arbitrate or litigate this amount if a settlement on a vastly reduced amount cannot be reached.

CONVERTIBLE NOTES PAYABLE AND_3

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIE (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Convertible notes payable	Schedule of Convertible notes payable September 30, December 31, 2021 2020 Various Convertible Notes (a)(f) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,010 339,011 GSH Note (d) 165,000 - Other Convertible Notes (e) 88,204 238,203 Convertible notes $ 635,714 $ 1,956,922	Schedule of Convertible notes payable December 31, December 31, 2020 2019 Various Convertible Notes(a) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) 1,336,208 882,500 Golock Capital, LLC Convertible Notes(c) 339,011 339,011 Other Convertible Notes(d) 238,203 299,069 Total Convertible Notes 1,956,922 1,564,080 Debt discount - (78,013 ) Convertible notes, net $ 1,956,922 $ 1,486,067

DERIVATIVE LIABILITY (Tables)

DERIVATIVE LIABILITY (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Schedule of derivative liabilities	Schedule of derivative liabilities fair value 9/30/21 12/31/20 Exercise Price $ 0.00595 0.007140 $ 0.00015 0.00018 Stock Price .0121 $ 0.0003 Risk-free interest rate 0.06 % 0.06 % Expected volatility 204.20 236 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 0 $ 3,156,582	Schedule of derivative liabilities fair value December 31, 2020 December 31, 2019 Exercise Price $ 0.0015 0.0018 $ 0.00015 0.00018 Stock Price .0114 $ 0.0003 Risk-free interest rate 0.17 % 1.59 % Expected volatility 737.80 236 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 3,156,582 $ 922,509
Stage It Corp [Member]
Schedule of derivative liabilities	Schedule of derivative liabilities September 30, December 31, Exercise Price $ 1.19 $ 1.19 Stock Price $ 1.59 $ 1.59 Risk-free interest rate 0.04 % 0.10 % Expected volatility 110.45 % 94.55 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 2,670,162 $ 2,404,981	Schedule of derivative liabilities December 31, December 31, Exercise Price $ 1.19 $ 1.19 Stock Price 1.59 $ 1.59 Risk-free interest rate 0.10 % 2.54 % Expected volatility 94.55 % 147.95 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 2,404,981 $ 2,099,025

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Equity [Abstract]
Schedule of warrants	Schedule of warrants Number Weighted of Average Warrants Exercise Balance outstanding, December 31, 2018 8,004,708 0.014 Warrants granted 15,800,319 .00475 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2019 23,805,027 0.079 Warrants granted - - Warrants exercised - - Balance outstanding, December 31, 2020 23,805,027 0.079 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, September 30, 2021 15,800,319 $ 0.0079	Schedule of warrants Number Weighted of Average Warrants Exercise Balance outstanding, December 31, 2018 8,004,708 0.014 Warrants granted 15,800,319 .00475 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2019 23,805,027 0.079 Warrants granted - - Warrants exercised - - Warrants expired or forfeited - - Balance outstanding and exercisable, December 31, 2020 23,805,027 $ 0.0079
Schedule of warrants outstanding and related prices	Schedule of warrants outstanding and related prices Outstanding and Exercisable Weighted Exercise Price Per Average Share Shares Life (Years) Exercise Price $ 0.004750 15,800,319 2.08 $ 0.00475	Schedule of warrants outstanding and related prices Outstanding and Exercisable Weighted Exercise Price Average Per Share Shares Life (Years) Exercise Price $ 0.010 0.015 8,004,708 0.14 $ 0.014 $ 0.004750 15,800,319 2.58 $ 0.00475

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of federal income tax rate and the actual tax rate	Schedule of federal income tax rate and the actual tax rate Year Ended 2020 2019 Federal statutory tax rate 21 % 21 % State tax, net of federal benefit 6 % 6 % Total tax rate 27 % 27 % Allowance ( 27 )% ( 27 )% Effective tax rate - % - %
Summary of deferred tax assets	Summary of deferred tax assets Year Ended 2020 2019 Net operating loss carryforwards $ 3,060,000 2,434,000 Accrued compensation - - Deferred tax asset 3,060,000 2,434,000 Valuation allowance (3,060,000 ) (2,434,000 ) Net deferred tax asset $ - $ -

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Schedule of accrued liabilities	Schedule of accrued liabilities 9/30/21 12/31/20 Accounts payable and accrued expense $ 527,430 587,230 Accrued interest 162,221 466,801 Accrued interest and penalties Golock (a) - 1,172,782 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities $ 834,910 2,372,072 (a) See Note 9 related to the reversal of interest and penalties for Golock.	Schedule of accrued liabilities December 31, December 31, Accounts payable and accrued expense (includes $41,250 to a former officer and director at December 31, 2019, Note 4) $ 587,230 577,115 Accrued interest 466,801 271,621 Accrued interest and penalties Golock(a) 1,172,782 - Soundstr Obligation 145,259 169,409 Total accounts payable and accrued liabilities $ 2,372,072 1,018,145 (a) The Company strongly disagrees with the accrued interest and penalties claimed by Golock in regard to their notes, and intends to arbitrate or litigate this amount if a settlement on a vastly reduced amount cannot be reached.
Stage It Corp [Member]
Schedule of accounts payable and accrued liabilities	Schedule of accounts payable and accrued liabilities September 30, 2021 December 31, 2020 Accounts payable $ 599,817 $ 427,086 Accrued liabilities (a)(b) 2,313,671 1,785,861 Accrued interest 840,197 650,654 Accrued interest- related parties 893,632 767,715 Total accounts payable and accrued liabilities $ 4,647,317 $ 2,404,981	Schedule of accounts payable and accrued liabilities December 31, December 31, Accounts payable $ 427,086 $ 223,795 Accrued liabilities (a)(b) 1,785,861 699,914 Accrued interest 650,654 502,916 Accrued interest- related parties 767,715 617,891 Total accounts payable and accrued liabilities $ 2,404,981 $ 2,044,516 (a) Includes $946,537 in liabilities due to artists and $791,172 in unredeemed outstanding notes purchased by users as of December 31, 2020 (b) Includes $398,729 in liabilities due to artists and $297,795 in unredeemed outstanding notes purchased by users as of December 31, 2019

CONVERTIBLE NOTES PAYABLE AND_4

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE RELATED PARTIES (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Convertible notes payable	Schedule of Convertible notes payable September 30, December 31, 2021 2020 Various Convertible Notes (a)(f) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,010 339,011 GSH Note (d) 165,000 - Other Convertible Notes (e) 88,204 238,203 Convertible notes $ 635,714 $ 1,956,922	Schedule of Convertible notes payable December 31, December 31, 2020 2019 Various Convertible Notes(a) $ 43,500 $ 43,500 Ylimit, LLC Convertible Notes (b) 1,336,208 882,500 Golock Capital, LLC Convertible Notes(c) 339,011 339,011 Other Convertible Notes(d) 238,203 299,069 Total Convertible Notes 1,956,922 1,564,080 Debt discount - (78,013 ) Convertible notes, net $ 1,956,922 $ 1,486,067

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2021
Stage It Corp [Member]
Schedule of notes payable	Schedule of notes payable September 30, December 31, Notes payable (a) $ 879,722 $ 179,000 Convertible notes related party-past due (b) 547,500 547,500 Convertible notes-past due (b) 315,000 315,000 Total notes payable $ 1,742,422 $ 1,041,500

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Short-term Debt [Line Items]
Operating loss							$ 4,553,777
Net cash (used in) operating activities					$ 913,466	$ 422,722	518,493	$ 501,905
Stockholders' Deficit	$ 13,405,633				13,405,633		16,755,676	12,201,899
Working capital	2,719,262				2,719,262		8,247,522
Cash	207,921		$ 11,229		207,921	11,229	4,458	52,096	$ 18,191
Net cash (used in) operations					913,466
Stockholders' Deficit	2,719,262				2,719,262
Net loss	365,161	$ (1,724,104)	6,874,231	$ 639,557	(3,350,043)	7,372,653	4,553,777	1,400,098
Stage It Corp [Member]
Short-term Debt [Line Items]
Net cash (used in) operating activities					897,425	(682,920)	(259,926)	10,506
Stockholders' Deficit	13,383,161				13,383,161		10,569,502	8,939,994
Working capital	8,988,706				8,988,706		6,668,922
Cash	69,342		$ 749,588		69,342	749,588	281,003	88,457	$ 98,963
Net loss					2,813,659	$ 617,171	1,629,508	$ 2,456,023
Cash on hand	69,342				69,342		281,033
ELOC [Member]
Short-term Debt [Line Items]
Cash	207,921				207,921
Equity line of credit	$ 722,215				$ 722,215
TGRI Merger Corp. [Member]
Short-term Debt [Line Items]
Business acquisition, equity interest issued or issuable, number of shares					50,762,987
Convertible Notes Payable [Member]
Short-term Debt [Line Items]
Proceeds from issuance of convertible notes							$ 150,000

SIGNIFICANT AND CRITICAL ACCO_4

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Office Equipment [Member] | Stage It Corp [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	3 years	3 years
Furniture and Fixtures [Member] | Stage It Corp [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	7 years	7 years
Vnue Inc. formerly TGRI [Member]
Property, Plant and Equipment [Line Items]
State of Incorporation	The State of Nevada	The State of Nevada
Entity Incorporation, Date of Incorporation	Apr. 4, 2006	Apr. 4, 2006
Attributable interest	100.00%	100.00%
Vnue Inc. (Vnue Washington) [Member]
Property, Plant and Equipment [Line Items]
State of Incorporation	The State of Washington	The State of Washington
Entity Incorporation, Date of Incorporation	Oct. 16, 2014	Oct. 16, 2014
Attributable interest	100.00%	100.00%
Vnue LLC [Member]
Property, Plant and Equipment [Line Items]
State of Incorporation	The State of Washington	The State of Washington
Entity Incorporation, Date of Incorporation	Aug. 1, 2013	Aug. 1, 2013
Attributable interest	100.00%	100.00%

SIGNIFICANT AND CRITICAL ACCO_5

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Derivative liability			$ 3,156,582	$ 922,509
Stage It Corp [Member]
Property, Plant and Equipment [Line Items]
Anti-dilutive shares			0
Revenue recognition, description	Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.		Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.
Fair value of derivative liabilities	$ 2,670,162		$ 2,404,981	2,099,025
Depreciation expense	17,767		4,468
Property and equipment	60,303		62,912
Fair value of derivative liabilities	2,670,163		2,404,091
Stage It Corp [Member] | Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense	200		200
Stage It Corp [Member] | Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense	1,000		1,000
Stage It Corp [Member] | Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	$ 60,303		$ 62,912	$ 0
Convertible Notes Payable [Member]
Property, Plant and Equipment [Line Items]
Anti-dilutive shares	11,100,841
Three Convertible Notes [Member]
Property, Plant and Equipment [Line Items]
Anti-dilutive shares			1,948,265,842
Warrant [Member]
Property, Plant and Equipment [Line Items]
Anti-dilutive shares	15,800,319		23,805,027

PREPAID EXPENSE (Details Narrat

PREPAID EXPENSE (Details Narrative)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
MT Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description of payment	the Company agreed to pay an advance of $100,000 against sales, to Matchbox Twenty and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020.	the Company agreed to pay an advance of $100,000 against sales, to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4th. We have recorded this amount as a prepaid expense on our consolidated balance sheet as of December 31, 2020.

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Sep. 15, 2017	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Related Party Transaction [Line Items]
Revenues		$ 2,714	$ 1,746	$ 9,295	$ 19,932	$ 22,474	$ 206,161
Direct costs of revenue		5,380		5,446	8,509	8,509	211,031
License cost				136	$ 465	1,124	10,308
Accrued payroll-officers		$ 239,750		$ 239,750		$ 209,750	68,000
Gain on settlement of vendor obligations							14,000
Forgivness of debt							14,000
Remaining of debt							$ 720
Common stock shares issued		1,372,757,161		1,372,757,161		1,211,495,162	770,883,602
Advances from former officer		$ 720		$ 720		$ 720	$ 720
Stage It Corp [Member]
Related Party Transaction [Line Items]
Common stock shares issued		972,614		972,614		972,614	972,614
Interest rate		18.00%		18.00%		18.00%
Due to related parties		$ 547,500		$ 547,500		$ 547,500	$ 547,500
Accrued interest						767,715	617,891
Accrued interest		$ 893,632		893,632		767,515
Debt Agreement [Member]
Related Party Transaction [Line Items]
Gain on settlement of vendor obligations							9,143
Chief Executive Officers' [Member]
Related Party Transaction [Line Items]
Compensation cost				$ 170,000		170,000
Compensation paid						129,500	102,000
Compensation outstanding						108,500	$ 68,000
Preferred stock shares issued							748,429
Mann [Member]
Related Party Transaction [Line Items]
Conversion of accrued payroll into common stock shares							$ 52,700
Shares issued in settlement of accounts payable, Shares							15,057,143
Shares issued in settlement of accounts payable, Amount							$ 40,654
Contributed capital							12,046
Mann [Member] | In May [Member] | Series A Preferred Stock [Member]
Related Party Transaction [Line Items]
Compensation cost							45,000
Advisory agreement, description	The Advisory Agreement provides for MANN’s continued and ongoing advisory services to the Company for nine (9) months and with automatic nine (9) months renewals unless terminated per the agreement. MANN is to receive $5,000 per month and 20,000 shares of common stock per month. Mann is still currently still engaged with the company, and serves as Executive Vice President as well as Director, as noted above.
Advance from related party								$ 40,000
share balance outstanding								$ 40,000
Common stock shares issued								11,428,571
Price per share								$ 0.0035
Compensation balance outstanding							$ 41,250
Accrued compensation						$ 60,000

ACCOUNTS PAYABLE AND ACCRUED _3

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)	Sep. 30, 2021		Dec. 31, 2020		Dec. 31, 2019
Accounts payable	$ 527,430		$ 587,230		$ 577,115
Accrued interest	162,221		466,801		271,621
Accrued interest and penalties Golock		[1]	1,172,782	[1],[2]		[2]
Soundstr Obligation	145,259		145,259		169,409
Total accounts payable and accrued liabilities	834,910		2,372,072		1,018,145
Stage It Corp [Member]
Accounts payable	599,817		427,086		223,795
Accrued interest	2,313,671		1,785,861		699,914
Total accounts payable and accrued liabilities	840,197		650,654		502,916
Accrued Liabilities	2,313,671	[3],[4]	1,785,861	[3],[4],[5],[6]	699,914	[5],[6]
Accrued interest	840,197		650,654		502,916
Accrued interest- related parties	893,632		767,715		617,891
Total accounts payable and accrued liabilities	$ 4,647,317		$ 2,404,981		$ 2,044,516
[1]	See Note 9 related to the reversal of interest and penalties for Golock.
[2]	The Company strongly disagrees with the accrued interest and penalties claimed by Golock in regard to their notes, and intends to arbitrate or litigate this amount if a settlement on a vastly reduced amount cannot be reached.
[3]	Includes $887,120 in liabilities due to artists, $846,477 in unredeemed outstanding notes purchased by users, and $376,703 in payroll liabilities as of September 30, 2021
[4]	Includes $946,537 in liabilities due to artists and $781,172 in unredeemed outstanding notes purchased by users as of December 31, 2020
[5]	Includes $398,729 in liabilities due to artists and $297,795 in unredeemed outstanding notes purchased by users as of December 31, 2019
[6]	Includes $946,537 in liabilities due to artists and $791,172 in unredeemed outstanding notes purchased by users as of December 31, 2020

PURCHASE LIABILITY (Details Nar

PURCHASE LIABILITY (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Oct. 16, 2017	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2020
Dividends Payable [Line Items]
Amortized value of intellectual property		$ 101,032
Dividend Declared [Member]
Dividends Payable [Line Items]
Acquisition cost	$ 50,000
Purchase liability	300,000
Purchase price	350,000
Total purchase of intellectual property	350,000
Amortized value of intellectual property	$ 116,668
Impairment charge		204,165	$ 204,165
Outstanding balance on acquisition		$ 300,000		$ 300,000

SHARES TO BE ISSUED (Details Na

SHARES TO BE ISSUED (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2021	Dec. 31, 2020
Short-term Debt [Line Items]
Common stock shares issued under plan, amount	$ 150
Common stock to be issued, shares		5,204,352	5,204,352	5,204,352	5,204,352
Common stock to be issued, value		$ 247,707	$ 247,707	$ 247,707	$ 247,707
PledgeMusic, Inc. [Member] | Business Acquisition [Member]
Short-term Debt [Line Items]
Common stock shares issued for amending existing convertible notes, shares		1,000,000	1,000,000
Common stock shares issued for amending existing convertible notes, amount		$ 3,500	$ 3,500
Convertible Notes Payable [Member]
Short-term Debt [Line Items]
Common stock shares issued under plan, shares		240,000	240,000
Common stock shares issued under plan, amount		$ 184	$ 184

NOTES PAYABLE -PAST DUE (Detail

NOTES PAYABLE -PAST DUE (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended		12 Months Ended
	Dec. 17, 2015	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Aug. 30, 2019	Apr. 30, 2019
Short-term Debt [Line Items]
Note payable description	On December 17, 2015, the Company issued a Promissory Note in the principal amount of $9,000. The note was due within 10 business days of the Company receiving notice of the effectiveness of its Form S-1 filed on February 22, 2016. Failure to make payment during that 10 business day period shall constitute an Event of Default, as a result of which the note will become immediately due and payable and the balance will bear interest at 7%. The Company’s Form S-1 was declared effective on March 8, 2016, and payment was due before March 22, 2016. The Company did not repay the note before March 22, 2016; therefore, the note is in default with an interest rate of 7%.
Principal amount	$ 9,000						$ 25,000
Interest amount						$ 5,000
Interest expense - Notes				$ 15,630	$ 5,630
Notes payable		$ 22,000		34,000	9,000
Note payable description	the Company receiving notice of the effectiveness of its Form S-1 filed on February 22, 2016. Failure to make payment during that 10-business day period shall constitute an Event of Default, as a result of which the note will become immediately due and payable, and the balance will bear interest at 7%. The Company’s Form S-1 was declared effective on March 8, 2016, and payment was due before March 22, 2016. The Company did not repay the note before March 22, 2016; therefore, the note is in default with an interest rate of 7%.
Debt instrument, maturity date	March 22, 2016	August 30, 2019
Interest rate	7.00%
Accrued interest expense - two notes		$ 34,246
Stage It Corp [Member]
Short-term Debt [Line Items]
Interest expense - Notes		464,023	$ 223,172	297,562	257,289
Notes payable		$ 1,742,422		1,041,500
Due to related party				547,500	547,500
Notes payable				$ 315,000	315,000
Interest rate		18.00%		18.00%
Compound interest				10.00%
Promissory Notes [Member] | Stage It Corp [Member]
Short-term Debt [Line Items]
Notes payable				$ 179,000	$ 179,000
Convertible Notes Payable [Member] | Stage It Corp [Member]
Short-term Debt [Line Items]
Due to related party				$ 275,000

CONVERTIBLE NOTES PAYABLES AND

CONVERTIBLE NOTES PAYABLES AND NOTES PAYABLE, RELATED PARTIES TO BE UPDATED (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2017
Short-term Debt [Line Items]
Total Convertible Notes	$ 635,714	$ 1,956,922	$ 1,564,080
Discount			(78,013)
Convertible notes, net	635,714	1,956,922	1,486,067	$ 583,750
Various Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes	43,500	43,500	43,500
Ylimit, LLCC convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes		1,336,208	882,500
Golock Capital, LLC Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes	339,010	339,011	339,011
Other Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes	$ 88,204	$ 238,203	$ 299,069

CONVERTIBLE NOTES PAYABLE AND_5

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIE (Details Narrative) - USD ($)	Mar. 04, 2019	Apr. 29, 2019	Feb. 02, 2018	Dec. 31, 2019	Dec. 31, 2017	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Aug. 25, 2017	May 09, 2016
Short-term Debt [Line Items]
Convertible notes payable				$ 484,331	$ 61,000				$ 484,331		$ 61,000
Debt instrument, forgivness									14,000
Debt instrument, principal amount				1,564,080					1,564,080
Unamortized note discount				78,013	198,025			$ 0	78,013		198,025
Increase/decrease in derivative liability								2,234,073	(1,179,556)
Note past due								238,303
Fair value of shares issued upon conversion				357,465					959,290
Debt conversion, converted instrument, amount								$ 56,466	$ 411,309
Debt conversion, converted instrument, shares issued								1,956,922	640,276,078
Loss on extinguishment of debt								$ 263,609	$ 548,029
Common stock shares issued upon conversion								1,948,265,842	3,334,494,813
Accrued interest								$ 8,600
Debt conversion, converted instrument, shares issued								440,111,560
Repayment of debt								$ 4,400
Convertible notes payable, net				1,486,067	583,750	$ 635,714		1,956,922	$ 1,486,067		583,750
Past due principal								620,714
Convertible note beneficial conversion feature											1,329,389
Amortization of debt discount						111,765	$ 78,013	78,013	389,793	$ 432,419	483,635
Financing cost									138,828		845,754
Unamortized notes discount										249,241
Debt discount				218,637					218,637
Golock Capital, LLC Convertible Notes [Member]
Short-term Debt [Line Items]
Convertible notes payable										302,067
Debt instrument, principal amount			$ 40,000	339,011	$ 191,750				339,011		$ 191,750
Interest rate			10.00%		10.00%						10.00%
Unamortized note discount			$ 40,000		$ 19,652					0	$ 19,652
Increase/decrease in derivative liability			$ 553,000
Warrants issued					4,804,708
Exercise price			$ 0.015		$ 0.014						$ 0.014
Debt discount			$ 5,000
Financing cost			$ 43,250
Golock [Member] | Amendment[Member]
Short-term Debt [Line Items]
Convertible notes payable				339,010					$ 339,010
Amendments, description		In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ending December 31, 2019 the Company issued new notes payable of $53,331 and $23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019, was $339,010. As of December 31, 2019, $285,679 of these notes were past due. As of December 31, 2020 all of the Golock notes amounting to $339,011 were past due. As a result Golock has assessed the Company additional penalties and interest pf $1,172,782. The Company has recorded this amount as an accrued liability as of December 1, 2020. The Company disagrees with the accrued interest and penalties due to Golock and intends to litigate this amount if a settlement on a vastly reduced amount, cannot be reached.
Debt Instrument, Description		They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion.
Debt conversion, converted instrument, shares issued									100,000,000
Five Lenders [Member]
Short-term Debt [Line Items]
Convertible notes payable										426,964
Unamortized note discount										179,162
Three Convertible Notes [Member]
Short-term Debt [Line Items]
Convertible notes payable				43,500		$ 43,500			$ 43,500	45,000
Debt instrument, forgivness	$ 1,500
Due to related parties				28,500				$ 28,500	28,500
Debt conversion, converted instrument, shares issued						718,945
Three Convertible Notes [Member] | YLimit, LLC [Member]
Short-term Debt [Line Items]
Convertible notes payable				882,500	$ 517,000				882,500		$ 517,000
Debt instrument, principal amount													$ 100,000
Interest rate													10.00%
Note amended to authorized total borrowing												$ 517,000
Unamortized note discount					$ 137,358						$ 137,358
Borrowing limit increased				175,000
Additional Notes [Member]
Short-term Debt [Line Items]
Convertible notes payable				$ 256,000					256,000	369,250
Increase/decrease in derivative liability									$ 357,465	559,397
Debt Instrument, Description									On April 29, 2019, one of the lenders entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, the Company issued (a) a warrant to purchase 2,966,986 shares of the Company’s common stock for a period of 48 months exercisable at a strike price of $.00475 with a fair value of $5,934, and (b) the conversion price of outstanding notes was changed from $.015 to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ended December 31, 2019, convertible notes of $388,207 and accrued interest were converted into 540,276,078 shares of common stock. As of December 31, 2019, the aggregate convertible notes balance to the five lenders was $299,069 and the related debt discount was $ 33,667. As of December 31, 2019, $96,069 of these notes were past due.
August 2014 [Member]
Short-term Debt [Line Items]
Note conversion price description								The Note Conversion Price is determined as follows: (a) if the Note is converted upon the Next Equity Financing, an amount equal to 80% of the price paid per share paid by the investors in the Next Equity Financing; (b) if the Note is converted in the event of a Corporate Transaction, a price per share derived by dividing a “pre-money” valuation of $8,000,000 by the number of shares outstanding immediately prior to the time of such conversion, on a fully diluted basis
On April 12, 2018, and again on August 15, 2018 [Member] | Convertible Promissory Note [Member] | YLimit, LLC [Member]
Short-term Debt [Line Items]
Convertible notes payable										707,500
Unamortized note discount										70,078
Borrowing limit increased								$ 190,500
Current borrowing limit								707,500
Increase/decrease in derivative liability										135,900
Additional borrowing										$ 190,500
February 9, 2020 [Member] | YLimit, LLC [Member]
Short-term Debt [Line Items]
Borrowing limit increased								1,366,208	$ 175,000
Funding amount from related party								$ 453,708

DERIVATIVE LIABILITY (Details)

DERIVATIVE LIABILITY (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Stock Price		$ 0.0114	$ 0.0003
Risk-free interest rate		0.17%
Risk-free interest rate	0.06%	0.06%	1.59%
Expected volatility		737.80%	236.00%
Expected life (in years)	1 year	1 year	1 year
Expected dividend yield	0.00%	0.00%	0.00%
Fair Value		$ 31,565,820,000	$ 9,225,090,000
Stock Price	$ 0.0121	$ 0.0003
Expected volatility	204.20%	236.00%
Fair Value	$ 0	$ 3,156,582
Stage It Corp [Member]
Derivative [Line Items]
Risk-free interest rate	0.04%	0.10%	2.54%
Expected life (in years)	1 year	1 year	1 year
Expected dividend yield	0.00%	0.00%	0.00%
Stock Price	$ 1.59	$ 1.59	$ 1.59
Expected volatility	110.45%	94.55%	147.95%
Exercise Price	$ 1.19	$ 1.19	$ 1.19
Fair Value:	$ 2,670,162	$ 2,404,981	$ 2,099,025
Minimum [Member]
Derivative [Line Items]
Stock Price		$ 0.0015	$ 0.00015
Stock Price	$ 0.00595	0.00015
Maximum [Member]
Derivative [Line Items]
Stock Price		0.0018	$ 0.00018
Stock Price	$ 0.007140	$ 0.00018

DERIVATIVE LIABILITY (Details N

DERIVATIVE LIABILITY (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability			$ 357,465
Additional derivative			189,186
Other income		$ 1,172,781	$ 1,179,556

STOCKHOLDERS DEFICIT (Details)

STOCKHOLDERS DEFICIT (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Equity [Abstract]
Number of Warrants Outstanding, Begining Balance	23,805,027	23,805,027	8,004,708
Weighted average exercise price or warrants outstanding, Begining Balance		$ 0.079	$ 0.014
Warrants granted			15,800,319
Weighted average exercise price, Warrants granted			$ 0.00475
Warrants exercised
Weighted average exercise price, Warrants exercised
Warrants expired or forfeited
Weighted average exercise price, Warrants expired or forfeited
Number of Warrants Outstanding, Ending Balance	15,800,319	23,805,027
Weighted average exercise price or warrants outstanding and exercisable, Ending Balance		$ 0.0079

STOCKHOLDERS DEFICIT (Details 1

STOCKHOLDERS DEFICIT (Details 1) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Class of Warrant or Right [Line Items]
Exercise price per share
Number of Warrants, Outstanding and Exercisable	23,805,027	23,805,027	8,004,708
Weighted average exercise price or warrants, Outstanding and Exercisable		$ 0.079	$ 0.014
Warrant One [Member]
Class of Warrant or Right [Line Items]
Exercise price per share			$ 0.004750
Number of Warrants, Outstanding and Exercisable			15,800,319
Weighted Average Remaining Contractual Life (Years)			2 years 6 months 29 days
Weighted average exercise price or warrants, Outstanding and Exercisable			$ 0.00475
Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Warrants, Outstanding and Exercisable			8,004,708
Weighted Average Remaining Contractual Life (Years)			1 month 20 days
Weighted average exercise price or warrants, Outstanding and Exercisable			$ 0.014
Warrant [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Exercise price per share			0.010
Warrant [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Exercise price per share			$ 0.015

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Jul. 02, 2019	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2021	May 22, 2019
Class of Stock [Line Items]
Common stock capitalized	2,000,000,000
Preferred stock capitalized	5,000,000
Common stock, shares authorized			2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares outstanding			1,211,495,162	770,883,602	1,372,757,161
Common stock, shares issued			1,211,495,162	770,883,602	1,372,757,161
Shares returned by former officer, shares				4,555,918
Shares returned by former officer, amount				$ 456
Common stock, shares issued for service, amount				$ 3,368
Profit upon extinguishment of debt		$ 80,227
Preferred stock, shares authorized			20,000,000	20,000,000	20,000,000
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares outstanding			4,126,776	4,126,776	4,250,579
Preferred stock, shares issued			4,126,776	4,126,776	4,250,579
Common stock par value			$ 0.0001	$ 0.0001	$ 0.0001
Stage It Corp [Member]
Class of Stock [Line Items]
Common stock, shares authorized			20,000,000	20,000,000	20,000,000
Common stock, shares outstanding			972,614	972,614	972,614
Common stock, shares issued			972,614	972,614	972,614
Common stock par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock conversion, description			Each share of preferred stock is convertible to common stock on a 1 for 1 basis
Two Convertible Noteholders [Member]
Class of Stock [Line Items]
warrants issued				15,800,319
Strike price				$ 0.00475
Financing expense				$ 36,533
Series A Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			20,000,000	20,000,000	20,000,000
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares outstanding			4,126,776	4,126,776	4,250,579
Preferred stock, shares issued			4,126,776	4,126,776	4,250,579
Preferred stock, designated						4,126,776
Non Redeemable Preferred Stock A [Member] | Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, par value			$ 0.0001
Non Redeemable Preferred Stock A 1 [Member] | Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, par value			0.0001
Non Redeemable Preferred Stock A 2 [Member] | Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, par value			0.0001
Non Redeemable Preferred Stock A 3 [Member] | Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, par value			$ 0.0001
Preferred Stock A [Member] | Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			400,000	400,000	400,000
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares outstanding			40,000	40,000	40,000
Preferred stock, shares issued			40,000	40,000	40,000
Preferred Stock A 1 [Member] | Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			3,000,000	3,000,000	3,000,000
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares outstanding			246,543	246,543	246,543
Preferred stock, shares issued			246,543	246,543	246,543
Preferred Stock A 2 [Member] | Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			2,000,000	2,000,000	2,000,000
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares outstanding			200,000	200,000	200,000
Preferred stock, shares issued			200,000	200,000	200,000
Preferred Stock A 3 [Member] | Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			300,000	300,000	300,000
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares outstanding			196,522	196,522	196,522
Preferred stock, shares issued			196,522	196,522	196,522
Vendor supplied consulting services [Member]
Class of Stock [Line Items]
Common stock, shares issued for services, shares			500,000	2,500,000
Common stock, shares issued for service, amount			$ 150	$ 3,368
Shares price				$ 27,096
Shares price per share				$ 0.05
Shares issued				541,912
Trading price of shares				$ 0.0013
Profit upon extinguishment of debt				$ 26,391

COMMITMENT AND CONTINGENCIES (D

COMMITMENT AND CONTINGENCIES (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Oct. 31, 2015	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2021	Dec. 31, 2019
Stage It Corp [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Commitments or contingencies			$ 0	$ 0	$ 0
Initial joint venture agreement [Member] | MRI [Member] | September 1, 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Terms of joint venture		The initial term of the JV is for nine (6) months and requires the Company to Pay MRI fifty percent (50%) of net revenue every quarter. As of September 30, 2021, no net revenue was generated from the JV.	The initial term of the JV is for nine (6) months and requires the Company to Pay MRI fifty percent (50%) of net revenue every quarter. As of December 31, 2020, no net revenue was generated from the JV.
Artist Agreement [Member] | I Break Horses [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description for commission receivable under agreement	Under the terms of the Artist Agreement, the Company shall handle rights clearing and distribution for I Break Horses recordings and receive 30% of the Net Income generated thereby. As of December 31, 2020, the Company had not earned any revenue under this agreement.

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal statutory tax rate	21.00%	21.00%
State tax, net of federal benefit	6.00%	6.00%
Total tax rate	27.00%	27.00%
Allowance	27.00%	27.00%
Effective tax rate
Net operating loss carryforwards	$ 3,060,000	$ 2,434,000
Accrued compensation
Deferred tax asset	3,060,000	2,434,000
Valuation allowance	(3,060,000)	(2,434,000)
Net deferred tax asset

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	12 Months Ended
	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 11,333,000
Operating loss carryforwards, expiration period	through 2032

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended			12 Months Ended
	Feb. 14, 2022	Nov. 30, 2021	Feb. 28, 2021	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2021
Subsequent Event [Line Items]
Debt conversion converted instrument amount				$ 56,466	$ 411,309
Stage It Corp [Member]
Subsequent Event [Line Items]
Interest rate				18.00%		18.00%
Proceeds from received amount				$ 700,922
Proceeds from loan				$ 250,000
Interest rate				15.00%
Advances amount				$ 35,000
Stage It Corp [Member] | Forecast [Member]
Subsequent Event [Line Items]
Percentage of ownership	100.00%
Stock transaction	$ 10,000,000
Cash	1,500,000
Stage It Corp [Member] | Restricted Stock [Member] | Forecast [Member]
Subsequent Event [Line Items]
Restricted stock	$ 8,500,000
Stage It Corp [Member] | Revenue Factoring Agreement [Member]
Subsequent Event [Line Items]
Proceeds from other				$ 415,922
Subsequent Event [Member]
Subsequent Event [Line Items]
Debt conversion converted instrument amount		$ 355,884
Sale of equity line, shares		$ 39,022,336
Price per share		$ 0.0912
Subsequent Event [Member] | Stage It Corp [Member]
Subsequent Event [Line Items]
Percentage of ownership	100.00%
Stock transaction	$ 10,000,000
Cash	1,500,000
Subsequent Event [Member] | Stage It Corp [Member] | Restricted Stock [Member]
Subsequent Event [Line Items]
Restricted stock	$ 8,500,000
Convertible Note Agreement [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt conversion converted instrument amount			$ 150,000
Conversion price			$ 0.0171
Convertible Note Agreement [Member] | Accredited investor [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from convertible notes			$ 165,000
Interest rate			8.00%
Maturity date			November 16, 2021

CONVERTIBLE NOTES PAYABLE AND_6

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE RELATED PARTIES (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Short-term Debt [Line Items]
Total Convertible Notes	$ 635,714	$ 1,956,922	$ 1,564,080
Various Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes	43,500	43,500	43,500
Ylimit, LLCC convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes		1,336,208	882,500
Golock Capital, LLC Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes	339,010	339,011	339,011
GSH Note [Member]
Short-term Debt [Line Items]
Total Convertible Notes	165,000
Other Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes	$ 88,204	$ 238,203	$ 299,069

STOCKHOLDER' DEFICIT (Details)

STOCKHOLDER' DEFICIT (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Number of Warrants Outstanding, Begining Balance	23,805,027	23,805,027	8,004,708
Weighted average exercise price or warrants outstanding, Begining Balance		$ 0.079	$ 0.014
Warrants granted			15,800,319
Weighted average exercise price, Warrants granted			$ 0.00475
Warrants exercised
Weighted average exercise price, Warrants exercised
Warrants expired or forfeited	(8,004,708)
Weighted average exercise price, Warrants expired or forfeited
Weighted average exercise price or warrants outstanding and exercisable, Ending Balance	$ 0.0079	$ 0.079
Number of Warrants Outstanding, Ending Balance	15,800,319	23,805,027

STOCKHOLDER' DEFICIT (Details 1

STOCKHOLDER' DEFICIT (Details 1) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Class of Warrant or Right [Line Items]
Exercise price per share
Number of Warrants, Outstanding and Exercisable	23,805,027	23,805,027	8,004,708
Weighted average exercise price or warrants, Outstanding and Exercisable		$ 0.079	$ 0.014
Warrant One [Member]
Class of Warrant or Right [Line Items]
Exercise price per share	$ 0.004750
Number of Warrants, Outstanding and Exercisable	15,800,319
Weighted Average Remaining Contractual Life (Years)	2 years 29 days
Weighted average exercise price or warrants, Outstanding and Exercisable	$ 0.00475

NOTES PAYABLE (Details)

NOTES PAYABLE (Details) - USD ($)		Sep. 30, 2021		Dec. 31, 2020		Dec. 31, 2019
Notes Payable, Current		$ 879,157		$ 34,000		$ 34,000
Total notes payable		22,000		34,000		9,000
Stage It Corp [Member]
Notes Payable, Current		879,722	[1]	179,000	[1]	$ 179,000
Convertible Notes Related Party past Due	[2]	547,500		547,500
Convertible Notes past Due	[2]	315,000		315,000
Total notes payable		$ 1,742,422		$ 1,041,500
[1]	Notes payable are comprised of a note for $179,000 at 15% interest in both period that is past due, a promissory note for $250,000 at 15% interest, advances of $35,000, and $415,922 in loans under the terms of revenue factoring agreement with three different lenders at an average rate of _____%
[2]	The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with several related parties (see Note 3) and third parties. These notes were issued to fund the early growth of the Company. The notes were issued at 18% interest compound annually and can only convert to common stock upon the occurrence of a qualified funding, which has not occurred

CONVERTIBLE NOTES PAYABLE AND_7

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE RELATED PARTIES (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended			4 Months Ended	9 Months Ended	12 Months Ended
	Apr. 29, 2019	Feb. 02, 2018	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2019	Dec. 31, 2017	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	May 09, 2016
Short-term Debt [Line Items]
Convertible notes payable					$ 484,331	$ 61,000			$ 484,331		$ 61,000
Conversion of principal amount				$ 1,162,800
Note payable			$ 22,000		9,000		$ 22,000	$ 34,000	$ 9,000
Conversion of accrued interest				$ 38,616
Shares issued upon conversion of convertible notes payable				75,195,174
Loss on the extinguishment of debt				$ 80,227
Conversion of notes into common stock								1,956,922	640,276,078
Debt instrument, principal amount					1,564,080				$ 1,564,080
Related debt discount					78,013	$ 198,025		$ 0	78,013		198,025
Increase/decrease in derivative liability								$ 2,234,073	(1,179,556)
Debt conversion, converted instrument, shares issued								440,111,560
Beneficial conversion feature											$ 1,329,389
Golock Capital, LLC Convertible Notes [Member]
Short-term Debt [Line Items]
Convertible notes payable										$ 302,067
Interest rate		10.00%				10.00%					10.00%
Debt instrument, principal amount		$ 40,000			339,011	$ 191,750			339,011		$ 191,750
Exercise price		$ 0.015				$ 0.014					$ 0.014
Warrants issued						4,804,708
Related debt discount		$ 40,000				$ 19,652				0	$ 19,652
Debt discount		$ 5,000
Warrant issued to common stock		2,500,000
Increase/decrease in derivative liability		$ 553,000
Financing cost		$ 43,250
Amount of additional penalties and interest							$ 1,172,782
YLimit, LLC [Member] | February 9, 2020 [Member]
Short-term Debt [Line Items]
Shares issued upon conversion of convertible notes payable							844,844,575
Borrowing limit increased								$ 1,366,208	175,000
Fundings							$ 119,000
Golock [Member] | Amendment[Member]
Short-term Debt [Line Items]
Debt conversion, converted instrument, amount					53,331				53,331
Convertible notes payable					339,010				339,010
Debt instrument, description	They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion.
Debt conversion, converted instrument, accured interest									$ 23,102
Debt conversion, converted instrument, shares issued									100,000,000
Notes past due					285,679				$ 285,679
Lender [Member] | Amendment[Member]
Short-term Debt [Line Items]
Shares issued upon conversion of convertible notes payable							16,981,339
Notes past due			73,204				$ 73,204
Officer [Member]
Short-term Debt [Line Items]
Advanced from related party			10,000
Balance due			$ 10,000				$ 10,000
GHS Investments [Member]
Short-term Debt [Line Items]
Interest rate			8.00%				8.00%
Convertible promissory note							$ 165,000
Conversion price							$ 171
Beneficial conversion feature							$ 106,765
Note Payable [Member]
Short-term Debt [Line Items]
Debt conversion, converted instrument, amount			$ 492,528				492,528
Convertible notes payable			364,629				364,629
Increase in convertible amount							107,000
Conversion of principal amount							857,157
Note payable			857,157				857,157
Three Convertible Notes [Member]
Short-term Debt [Line Items]
Convertible notes payable			$ 43,500		43,500		$ 43,500		43,500	45,000
Due to related parties					28,500			$ 28,500	28,500
Conversion of notes into common stock							718,945
Three Convertible Notes [Member] | YLimit, LLC [Member]
Short-term Debt [Line Items]
Convertible notes payable					882,500	517,000			882,500		517,000
Interest rate												10.00%
Borrowing limit increased					175,000
Debt instrument, principal amount												$ 100,000
Related debt discount						$ 137,358					$ 137,358
Additional Notes [Member]
Short-term Debt [Line Items]
Convertible notes payable					$ 256,000				256,000	369,250
Increase/decrease in derivative liability									$ 357,465	$ 559,397
Debt instrument, description									On April 29, 2019, one of the lenders entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, the Company issued (a) a warrant to purchase 2,966,986 shares of the Company’s common stock for a period of 48 months exercisable at a strike price of $.00475 with a fair value of $5,934, and (b) the conversion price of outstanding notes was changed from $.015 to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion. During the year ended December 31, 2019, convertible notes of $388,207 and accrued interest were converted into 540,276,078 shares of common stock. As of December 31, 2019, the aggregate convertible notes balance to the five lenders was $299,069 and the related debt discount was $ 33,667. As of December 31, 2019, $96,069 of these notes were past due.